+关注
Desmondsim
暂无个人介绍
IP属地:未知
363
关注
16
粉丝
0
主题
0
勋章
主贴
热门
Desmondsim
2021-10-16
Like
抱歉,原内容已删除
Desmondsim
2021-07-14
Wowew
抱歉,原内容已删除
Desmondsim
2021-11-15
Like
抱歉,原内容已删除
Desmondsim
2021-06-22
Pls like and comment
抱歉,原内容已删除
Desmondsim
2021-10-27
Like
Microsoft beats revenue expectations<blockquote>微软营收超出预期</blockquote>
Desmondsim
2021-10-25
Like
抱歉,原内容已删除
Desmondsim
2021-07-16
Ok
Exela Technologies soars 10% amid listing of option contracts on NYSE Arca<blockquote>Exela Technologies在纽约证券交易所Arca上市期权合约,股价飙升10%</blockquote>
Desmondsim
2021-10-11
Like
抱歉,原内容已删除
Desmondsim
2021-10-07
Like
抱歉,原内容已删除
Desmondsim
2021-09-13
Like
抱歉,原内容已删除
去老虎APP查看更多动态
{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3581894830339885","uuid":"3581894830339885","gmtCreate":1618803455588,"gmtModify":1618899485594,"name":"Desmondsim","pinyin":"desmondsim","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/9484cf4599b477a3985c44fe04da87b3","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":16,"headSize":363,"tweetSize":255,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.09.02","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":2,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":604861673,"gmtCreate":1639371231070,"gmtModify":1639371231321,"author":{"id":"3581894830339885","authorId":"3581894830339885","name":"Desmondsim","avatar":"https://static.tigerbbs.com/9484cf4599b477a3985c44fe04da87b3","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581894830339885","idStr":"3581894830339885"},"themes":[],"htmlText":"Loke","listText":"Loke","text":"Loke","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/604861673","repostId":"1171394291","repostType":4,"repost":{"id":"1171394291","kind":"news","pubTimestamp":1639366890,"share":"https://www.laohu8.com/m/news/1171394291?lang=zh_CN&edition=full","pubTime":"2021-12-13 11:41","market":"us","language":"en","title":"Apple's $3 trillion market cap to be a 'watershed moment' for company<blockquote>苹果3万亿美元市值将成为公司的“分水岭时刻”</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1171394291","media":"Seeking Alpha","summary":"As many companies begin to gear down for the Christmas and New Year holidays, there remains one tech","content":"<p>As many companies begin to gear down for the Christmas and New Year holidays, there remains one tech stalwart that is on the brink of a milestone that no other company in history has achieved: Apple.</p><p><blockquote>随着许多公司开始为圣诞节和新年假期做好准备,仍有一家科技巨头正处于历史上其他公司从未实现过的里程碑的边缘:苹果。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/8c6ec3289e9b74b1c20fa47308bcbb20\" tg-width=\"1536\" tg-height=\"1063\" width=\"100%\" height=\"auto\"><span>Justin Sullivan/Getty Images News</span></p><p><blockquote><p class=\"t-img-caption\"><span>贾斯汀·沙利文/盖蒂图片社新闻</span></p></blockquote></p><p> The most-iconic of all tech companies stands a good chance of reaching $3 trillion in market capitalization this week. Apple(NASDAQ:AAPL)finished Friday with a valuation of $2.944 trillion, so all Wall Street needs to do now is add $56 billion to the iPhone maker's stock value and Apple (AAPL) will stand alone in the $3 trillion club.</p><p><blockquote>所有科技公司中最具标志性的公司本周的市值很有可能达到3万亿美元。苹果(纳斯达克股票代码:AAPL)周五收盘估值为2.944万亿美元,因此华尔街现在需要做的就是将这家iPhone制造商的股票价值增加560亿美元,苹果(AAPL)将在3万亿美元俱乐部中独树一帜。</blockquote></p><p> To put that amount in some perspective, Apple (AAPL) became the first company to hit $1 trillion in market cap in 2018--or, 42 years after Steve Jobs and Steve Wozniak founded Apple (AAPL) in a garage in Cupertino, Calif. It then took Apple just until 2020 to reach $2 trillion in market cap. Right now, the only other company worth more than $2 trillion is Microsoft(NASDAQ:MSFT), which ended last week with a market cap of $2.57 trillion.</p><p><blockquote>从某种角度来看,苹果(AAPL)在2018年成为第一家市值达到1万亿美元的公司,也就是史蒂夫·乔布斯(Steve Jobs)和史蒂夫·沃兹尼亚克(Steve Wozniak)在库比蒂诺的车库里创立苹果(AAPL)42年后,加利福尼亚州。直到2020年,苹果的市值才达到2万亿美元。目前,唯一一家市值超过2万亿美元的公司是微软(纳斯达克股票代码:MSFT),该公司上周收盘市值为2.57万亿美元。</blockquote></p><p> \"The Street is starting to better appreciate the robust fundamental story into 2022 for [Apple Chief Executive] Tim Cook & Co.,\" said Wedbush analyst Dan Ives, in a research note on Sunday. \"Hitting $3 trillion is another watershed moment for Apple as the company continues to prove the doubters wrong with the renaissance of growth story playing out in Cupertino.\"</p><p><blockquote>Wedbush分析师Dan Ives在周日的一份研究报告中表示:“华尔街开始更好地认识到[苹果首席执行官]蒂姆·库克公司(Tim Cook&Co.)2022年强劲的基本面。”“达到3万亿美元是苹果的另一个分水岭,因为该公司继续证明怀疑者对库比蒂诺复兴增长故事的看法是错误的。”</blockquote></p><p> While Apple's (AAPL) iPhone sales continue to be the biggest source of the company's strength--iPhones accounted for almost $39 billion of Apple's $83.4 billion in fiscal fourth-quarter sales--Ives said the \"linchpin\" of Apple's (AAPL) growing valuation is its services business.</p><p><blockquote>虽然苹果(AAPL)的iPhone销量仍然是该公司实力的最大来源——iPhone在苹果第四财季834亿美元的销售额中占了近390亿美元——但Ives表示,苹果(AAPL)增长的“关键”估值是其服务业务。</blockquote></p><p> Services, which include items such as sales from the App Store and subscriptions to everything from Apple TV+ to iCloud storage plans, brought in $18.3 billion in revenue in Apple's (AAPL) most-recent quarter. Ives estimates that Apple's (AAPL) services business \"is worth $1.5 trillion in the eyes of the Street,\" and is benefiting from being coupled with a hardware ecosystem that \"is in the midst of its strongest product cycle in over a decade, led by iPhone 13.\"</p><p><blockquote>苹果(AAPL)最近一个季度的服务收入为183亿美元,其中包括App Store的销售以及从苹果TV+到iCloud存储计划的订阅等项目。Ives估计,苹果(AAPL)的服务业务“在华尔街眼中价值1.5万亿美元”,并且受益于与硬件生态系统的结合,该生态系统“正处于十多年来最强劲的产品周期中,以iPhone 13为首。”</blockquote></p><p> Even issues related to component supplies that could impede Apple's (AAPL) path toward a market cap for $3 trillion or more are likely to be little more than minor speedbumps for the company to overcome, in Ives opinion.</p><p><blockquote>Ives认为,即使与零部件供应相关的问题可能会阻碍苹果(AAPL)实现3万亿美元或更高市值的道路,也可能只不过是该公司需要克服的小障碍。</blockquote></p><p> \"Supply shortages of roughly 15 million iPhone units globally remain an issue that should moderate into early 2022,\" Ives said. \"Importantly, the underlying demand story is our focus into 2022 and we believe is the ultimate driver of the stock going forward.\"</p><p><blockquote>艾夫斯表示:“全球约1500万部iPhone的供应短缺仍然是一个问题,到2022年初应该会有所缓解。”“重要的是,潜在的需求故事是我们2022年的重点,我们相信这是该股未来发展的最终驱动力。”</blockquote></p><p> Ives estimates that Apple (AAPL) will sell more than 40 million iPhones during the end-of-the-year holiday season, and that China alone is set to see 15 million upgrades to the iPhone 13 during the quarter that concludes at the end of December.</p><p><blockquote>Ives估计,苹果(AAPL)在年底假期期间将售出超过4000万部iPhone,仅在中国,在截至年底的季度内,iPhone 13的升级量就将达到1500万部。十二月。</blockquote></p><p> Along with the iPhone, Ives said many signs point toward Apple (AAPL) rolling out its first augmented reality [AR] glasses by the summer of 2022, and that move could add $20 a share to the company's valuation. Morgan Stanley analyst Katy Huberty also recently said that Apple (AAPL) should see success with its AR glasses due to its long-time track record of entering consumer markets with successful new products.</p><p><blockquote>Ives表示,除了iPhone之外,许多迹象表明苹果(AAPL)将在2022年夏季推出首款增强现实[AR]眼镜,此举可能会使该公司每股估值增加20美元。Morgan Stanley分析师Katy Huberty最近也表示,苹果(AAPL)的AR眼镜应该会取得成功,因为该公司长期以来一直以成功的新产品进入消费市场。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Apple's $3 trillion market cap to be a 'watershed moment' for company<blockquote>苹果3万亿美元市值将成为公司的“分水岭时刻”</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nApple's $3 trillion market cap to be a 'watershed moment' for company<blockquote>苹果3万亿美元市值将成为公司的“分水岭时刻”</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Seeking Alpha</strong><span class=\"h-time small\">2021-12-13 11:41</span>\n</p>\n</h4>\n</header>\n<article>\n<p>As many companies begin to gear down for the Christmas and New Year holidays, there remains one tech stalwart that is on the brink of a milestone that no other company in history has achieved: Apple.</p><p><blockquote>随着许多公司开始为圣诞节和新年假期做好准备,仍有一家科技巨头正处于历史上其他公司从未实现过的里程碑的边缘:苹果。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/8c6ec3289e9b74b1c20fa47308bcbb20\" tg-width=\"1536\" tg-height=\"1063\" width=\"100%\" height=\"auto\"><span>Justin Sullivan/Getty Images News</span></p><p><blockquote><p class=\"t-img-caption\"><span>贾斯汀·沙利文/盖蒂图片社新闻</span></p></blockquote></p><p> The most-iconic of all tech companies stands a good chance of reaching $3 trillion in market capitalization this week. Apple(NASDAQ:AAPL)finished Friday with a valuation of $2.944 trillion, so all Wall Street needs to do now is add $56 billion to the iPhone maker's stock value and Apple (AAPL) will stand alone in the $3 trillion club.</p><p><blockquote>所有科技公司中最具标志性的公司本周的市值很有可能达到3万亿美元。苹果(纳斯达克股票代码:AAPL)周五收盘估值为2.944万亿美元,因此华尔街现在需要做的就是将这家iPhone制造商的股票价值增加560亿美元,苹果(AAPL)将在3万亿美元俱乐部中独树一帜。</blockquote></p><p> To put that amount in some perspective, Apple (AAPL) became the first company to hit $1 trillion in market cap in 2018--or, 42 years after Steve Jobs and Steve Wozniak founded Apple (AAPL) in a garage in Cupertino, Calif. It then took Apple just until 2020 to reach $2 trillion in market cap. Right now, the only other company worth more than $2 trillion is Microsoft(NASDAQ:MSFT), which ended last week with a market cap of $2.57 trillion.</p><p><blockquote>从某种角度来看,苹果(AAPL)在2018年成为第一家市值达到1万亿美元的公司,也就是史蒂夫·乔布斯(Steve Jobs)和史蒂夫·沃兹尼亚克(Steve Wozniak)在库比蒂诺的车库里创立苹果(AAPL)42年后,加利福尼亚州。直到2020年,苹果的市值才达到2万亿美元。目前,唯一一家市值超过2万亿美元的公司是微软(纳斯达克股票代码:MSFT),该公司上周收盘市值为2.57万亿美元。</blockquote></p><p> \"The Street is starting to better appreciate the robust fundamental story into 2022 for [Apple Chief Executive] Tim Cook & Co.,\" said Wedbush analyst Dan Ives, in a research note on Sunday. \"Hitting $3 trillion is another watershed moment for Apple as the company continues to prove the doubters wrong with the renaissance of growth story playing out in Cupertino.\"</p><p><blockquote>Wedbush分析师Dan Ives在周日的一份研究报告中表示:“华尔街开始更好地认识到[苹果首席执行官]蒂姆·库克公司(Tim Cook&Co.)2022年强劲的基本面。”“达到3万亿美元是苹果的另一个分水岭,因为该公司继续证明怀疑者对库比蒂诺复兴增长故事的看法是错误的。”</blockquote></p><p> While Apple's (AAPL) iPhone sales continue to be the biggest source of the company's strength--iPhones accounted for almost $39 billion of Apple's $83.4 billion in fiscal fourth-quarter sales--Ives said the \"linchpin\" of Apple's (AAPL) growing valuation is its services business.</p><p><blockquote>虽然苹果(AAPL)的iPhone销量仍然是该公司实力的最大来源——iPhone在苹果第四财季834亿美元的销售额中占了近390亿美元——但Ives表示,苹果(AAPL)增长的“关键”估值是其服务业务。</blockquote></p><p> Services, which include items such as sales from the App Store and subscriptions to everything from Apple TV+ to iCloud storage plans, brought in $18.3 billion in revenue in Apple's (AAPL) most-recent quarter. Ives estimates that Apple's (AAPL) services business \"is worth $1.5 trillion in the eyes of the Street,\" and is benefiting from being coupled with a hardware ecosystem that \"is in the midst of its strongest product cycle in over a decade, led by iPhone 13.\"</p><p><blockquote>苹果(AAPL)最近一个季度的服务收入为183亿美元,其中包括App Store的销售以及从苹果TV+到iCloud存储计划的订阅等项目。Ives估计,苹果(AAPL)的服务业务“在华尔街眼中价值1.5万亿美元”,并且受益于与硬件生态系统的结合,该生态系统“正处于十多年来最强劲的产品周期中,以iPhone 13为首。”</blockquote></p><p> Even issues related to component supplies that could impede Apple's (AAPL) path toward a market cap for $3 trillion or more are likely to be little more than minor speedbumps for the company to overcome, in Ives opinion.</p><p><blockquote>Ives认为,即使与零部件供应相关的问题可能会阻碍苹果(AAPL)实现3万亿美元或更高市值的道路,也可能只不过是该公司需要克服的小障碍。</blockquote></p><p> \"Supply shortages of roughly 15 million iPhone units globally remain an issue that should moderate into early 2022,\" Ives said. \"Importantly, the underlying demand story is our focus into 2022 and we believe is the ultimate driver of the stock going forward.\"</p><p><blockquote>艾夫斯表示:“全球约1500万部iPhone的供应短缺仍然是一个问题,到2022年初应该会有所缓解。”“重要的是,潜在的需求故事是我们2022年的重点,我们相信这是该股未来发展的最终驱动力。”</blockquote></p><p> Ives estimates that Apple (AAPL) will sell more than 40 million iPhones during the end-of-the-year holiday season, and that China alone is set to see 15 million upgrades to the iPhone 13 during the quarter that concludes at the end of December.</p><p><blockquote>Ives估计,苹果(AAPL)在年底假期期间将售出超过4000万部iPhone,仅在中国,在截至年底的季度内,iPhone 13的升级量就将达到1500万部。十二月。</blockquote></p><p> Along with the iPhone, Ives said many signs point toward Apple (AAPL) rolling out its first augmented reality [AR] glasses by the summer of 2022, and that move could add $20 a share to the company's valuation. Morgan Stanley analyst Katy Huberty also recently said that Apple (AAPL) should see success with its AR glasses due to its long-time track record of entering consumer markets with successful new products.</p><p><blockquote>Ives表示,除了iPhone之外,许多迹象表明苹果(AAPL)将在2022年夏季推出首款增强现实[AR]眼镜,此举可能会使该公司每股估值增加20美元。Morgan Stanley分析师Katy Huberty最近也表示,苹果(AAPL)的AR眼镜应该会取得成功,因为该公司长期以来一直以成功的新产品进入消费市场。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源:<a href=\"https://seekingalpha.com/news/3779362-apple-nearing-watershed-moment-of-3-trillion-in-market-cap\">Seeking Alpha</a></p>\n<p>为提升您的阅读体验,我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"source_url":"https://seekingalpha.com/news/3779362-apple-nearing-watershed-moment-of-3-trillion-in-market-cap","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1171394291","content_text":"As many companies begin to gear down for the Christmas and New Year holidays, there remains one tech stalwart that is on the brink of a milestone that no other company in history has achieved: Apple.\nJustin Sullivan/Getty Images News\nThe most-iconic of all tech companies stands a good chance of reaching $3 trillion in market capitalization this week. Apple(NASDAQ:AAPL)finished Friday with a valuation of $2.944 trillion, so all Wall Street needs to do now is add $56 billion to the iPhone maker's stock value and Apple (AAPL) will stand alone in the $3 trillion club.\nTo put that amount in some perspective, Apple (AAPL) became the first company to hit $1 trillion in market cap in 2018--or, 42 years after Steve Jobs and Steve Wozniak founded Apple (AAPL) in a garage in Cupertino, Calif. It then took Apple just until 2020 to reach $2 trillion in market cap. Right now, the only other company worth more than $2 trillion is Microsoft(NASDAQ:MSFT), which ended last week with a market cap of $2.57 trillion.\n\"The Street is starting to better appreciate the robust fundamental story into 2022 for [Apple Chief Executive] Tim Cook & Co.,\" said Wedbush analyst Dan Ives, in a research note on Sunday. \"Hitting $3 trillion is another watershed moment for Apple as the company continues to prove the doubters wrong with the renaissance of growth story playing out in Cupertino.\"\nWhile Apple's (AAPL) iPhone sales continue to be the biggest source of the company's strength--iPhones accounted for almost $39 billion of Apple's $83.4 billion in fiscal fourth-quarter sales--Ives said the \"linchpin\" of Apple's (AAPL) growing valuation is its services business.\nServices, which include items such as sales from the App Store and subscriptions to everything from Apple TV+ to iCloud storage plans, brought in $18.3 billion in revenue in Apple's (AAPL) most-recent quarter. Ives estimates that Apple's (AAPL) services business \"is worth $1.5 trillion in the eyes of the Street,\" and is benefiting from being coupled with a hardware ecosystem that \"is in the midst of its strongest product cycle in over a decade, led by iPhone 13.\"\nEven issues related to component supplies that could impede Apple's (AAPL) path toward a market cap for $3 trillion or more are likely to be little more than minor speedbumps for the company to overcome, in Ives opinion.\n\"Supply shortages of roughly 15 million iPhone units globally remain an issue that should moderate into early 2022,\" Ives said. \"Importantly, the underlying demand story is our focus into 2022 and we believe is the ultimate driver of the stock going forward.\"\nIves estimates that Apple (AAPL) will sell more than 40 million iPhones during the end-of-the-year holiday season, and that China alone is set to see 15 million upgrades to the iPhone 13 during the quarter that concludes at the end of December.\nAlong with the iPhone, Ives said many signs point toward Apple (AAPL) rolling out its first augmented reality [AR] glasses by the summer of 2022, and that move could add $20 a share to the company's valuation. Morgan Stanley analyst Katy Huberty also recently said that Apple (AAPL) should see success with its AR glasses due to its long-time track record of entering consumer markets with successful new products.","news_type":1,"symbols_score_info":{"AAPL":0.9}},"isVote":1,"tweetType":1,"viewCount":3859,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":606793741,"gmtCreate":1638925751478,"gmtModify":1638925751976,"author":{"id":"3581894830339885","authorId":"3581894830339885","name":"Desmondsim","avatar":"https://static.tigerbbs.com/9484cf4599b477a3985c44fe04da87b3","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581894830339885","idStr":"3581894830339885"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/606793741","repostId":"608029513","repostType":1,"repost":{"id":608029513,"gmtCreate":1638583370869,"gmtModify":1638806042879,"author":{"id":"3574968450404111","authorId":"3574968450404111","name":"B.God","avatar":"https://static.tigerbbs.com/8fba96cdefc2640a0413c00996aed28d","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3574968450404111","idStr":"3574968450404111"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TSLA\">$Tesla Motors(TSLA)$</a>Dumb dumb Tesla retail investors got played by Elon Musk and Cathie Woods. When CEO is selling big along with other smart money like big institutions and Cathie Wood, its already a big red flag. You cantbe that retard to need Elon Musk to tell you directly \"Sell with me now\". He being a nice CEO by using twitter poll to indicate indirectly that he is selling already as Tesla is gonna be in bear marker. As the CEO, he cant spoon feed you directly and warn you faster sell.","listText":"<a href=\"https://laohu8.com/S/TSLA\">$Tesla Motors(TSLA)$</a>Dumb dumb Tesla retail investors got played by Elon Musk and Cathie Woods. When CEO is selling big along with other smart money like big institutions and Cathie Wood, its already a big red flag. You cantbe that retard to need Elon Musk to tell you directly \"Sell with me now\". He being a nice CEO by using twitter poll to indicate indirectly that he is selling already as Tesla is gonna be in bear marker. As the CEO, he cant spoon feed you directly and warn you faster sell.","text":"$Tesla Motors(TSLA)$Dumb dumb Tesla retail investors got played by Elon Musk and Cathie Woods. When CEO is selling big along with other smart money like big institutions and Cathie Wood, its already a big red flag. You cantbe that retard to need Elon Musk to tell you directly \"Sell with me now\". He being a nice CEO by using twitter poll to indicate indirectly that he is selling already as Tesla is gonna be in bear marker. As the CEO, he cant spoon feed you directly and warn you faster sell.","images":[],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/608029513","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":3687,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":609414330,"gmtCreate":1638317365308,"gmtModify":1638317365398,"author":{"id":"3581894830339885","authorId":"3581894830339885","name":"Desmondsim","avatar":"https://static.tigerbbs.com/9484cf4599b477a3985c44fe04da87b3","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581894830339885","idStr":"3581894830339885"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/609414330","repostId":"1135257969","repostType":4,"isVote":1,"tweetType":1,"viewCount":2906,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":873684439,"gmtCreate":1636938412602,"gmtModify":1636938412692,"author":{"id":"3581894830339885","authorId":"3581894830339885","name":"Desmondsim","avatar":"https://static.tigerbbs.com/9484cf4599b477a3985c44fe04da87b3","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581894830339885","idStr":"3581894830339885"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":10,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/873684439","repostId":"1102708415","repostType":4,"isVote":1,"tweetType":1,"viewCount":3704,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":873134437,"gmtCreate":1636877814355,"gmtModify":1636877814445,"author":{"id":"3581894830339885","authorId":"3581894830339885","name":"Desmondsim","avatar":"https://static.tigerbbs.com/9484cf4599b477a3985c44fe04da87b3","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581894830339885","idStr":"3581894830339885"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/873134437","repostId":"1103944030","repostType":4,"isVote":1,"tweetType":1,"viewCount":3500,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":873047038,"gmtCreate":1636812926918,"gmtModify":1636812927046,"author":{"id":"3581894830339885","authorId":"3581894830339885","name":"Desmondsim","avatar":"https://static.tigerbbs.com/9484cf4599b477a3985c44fe04da87b3","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581894830339885","idStr":"3581894830339885"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/873047038","repostId":"1102251183","repostType":4,"repost":{"id":"1102251183","kind":"news","pubTimestamp":1636772424,"share":"https://www.laohu8.com/m/news/1102251183?lang=zh_CN&edition=full","pubTime":"2021-11-13 11:00","market":"us","language":"en","title":"Pfizer Shows Its R&D Is Strong. It’s a Good Sign for the Stock.<blockquote>辉瑞显示其研发实力雄厚。这对该股来说是一个好兆头。</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1102251183","media":"Barrons","summary":"Pfizer’s chief scientific officer, Mikael Dolsten, sounded giddy when reached via telephone early Mo","content":"<p>Pfizer’s chief scientific officer, Mikael Dolsten, sounded giddy when reached via telephone early Monday morning. It was just days after his company knocked the socks off the market with the news that its Covid-19 antiviral had cut the risk of hospitalization by 89% in high-risk adults.</p><p><blockquote>周一早上,辉瑞公司首席科学官米凯尔·多尔斯滕(Mikael Dolsten)接到电话时,听起来很头晕。就在几天前,他的公司宣布其Covid-19抗病毒药物将高危成年人的住院风险降低了89%。</blockquote></p><p> “It can’t be just a random thing, that you’re able to beat this type of world record and get a grand slam at the same time by chance,” Dolsten said, scrambling sports metaphors as he sought to illustrate the magnitude of Pfizer’s twin wins: the development of a stunningly effective Covid-19 vaccine in just 10 months, followed a year later by the development of a similarly stunning Covid-19 antiviral.</p><p><blockquote>多尔斯滕说:“你能够打破这种类型的世界纪录,同时偶然获得大满贯,这不可能只是一件随机的事情。”他在试图说明辉瑞的双重胜利:在短短10个月内开发出了一种效果惊人的Covid-19疫苗,一年后又开发出了一种同样令人惊叹的Covid-19抗病毒药物。</blockquote></p><p> Two years ago, Pfizer (ticker: PFE) CEO Albert Bourla asked investors to take a big gamble on the research-and-development operation that Dolsten has rebuilt over the course of more than a decade. That bet is looking smarter than ever.</p><p><blockquote>两年前,辉瑞(股票代码:PFE)首席执行官阿尔伯特·布尔拉(Albert Bourla)要求投资者对多尔斯滕十多年来重建的研发业务进行豪赌。这个赌注看起来比以往任何时候都更聪明。</blockquote></p><p> Bourla has gotten rid of Pfizer’s off-patent drugs division and the last of its consumer health products, leaving behind a pure-play biopharma company that will live or die on the strength of Dolsten’s science.</p><p><blockquote>Bourla已经摆脱了辉瑞的非专利药物部门及其最后的消费者健康产品,留下了一家纯粹的生物制药公司,该公司的生死存亡都取决于Dolsten的科学实力。</blockquote></p><p> In a cover story in November 2019, <i>Barron’s</i> argued that Bourla and Dolsten could pull it off.</p><p><blockquote>在2019年11月的一篇封面报道中,<i>巴伦周刊</i>认为布尔拉和多尔斯滕可以成功。</blockquote></p><p> The new antiviral data reaffirms the case for Pfizer that <i>Barron’s</i> made two years ago. Continuing to profit off the pandemic, however, brings new risks, as criticism grows over the global inequity in vaccine distribution. Low-income nations account for less than 1% of the more than seven billion doses administered worldwide. If distribution of Pfizer’s antiviral continues to favor wealthy nations, the company’s stock could ultimately suffer.</p><p><blockquote>新的抗病毒数据再次证实了辉瑞的理由<i>巴伦周刊</i>两年前做的。然而,随着对全球疫苗分配不平等的批评越来越多,继续从大流行中获利会带来新的风险。在全球超过70亿剂疫苗中,低收入国家仅占不到1%。如果辉瑞抗病毒药物的分销继续有利于富裕国家,该公司的股票最终可能会受到影响。</blockquote></p><p> Pfizer’s shares surged 10.9% the day the data came out, their best daily showing in at least 20 years. Still, with the stock now changing hands at around $50, investors continue to undervalue the company. Investors are pricing Pfizer at 12 times next year’s expected earnings, cheaper than peers like Johnson & Johnson (JNJ) and Eli Lilly (LLY).</p><p><blockquote>数据公布当天,辉瑞股价飙升10.9%,创下至少20年来的最佳单日表现。尽管如此,由于该股目前易手价格约为50美元,投资者继续低估该公司的价值。投资者对辉瑞的定价是明年预期收益的12倍,低于强生(JNJ)和礼来(LLY)等同行。</blockquote></p><p> The Pfizer discount can be attributed to concerns over the patent cliff the drugmaker faces at the end of the decade. The company stands to lose exclusivity over a handful of drugs that bring in billions in annual revenue.</p><p><blockquote>辉瑞的折扣可归因于对该制药商在本世纪末面临专利悬崖的担忧。该公司将失去对少数年收入数十亿美元的药物的独家经营权。</blockquote></p><p> The worries are legitimate, but Pfizer’s scientific coup should give investors confidence that the company’s science can carry it safely over that cliff. It may take time for the market to catch up, but for long-term investors, it’s a promising opportunity.</p><p><blockquote>这些担忧是合理的,但辉瑞的科学政变应该让投资者相信该公司的科学能够安全地越过悬崖。市场可能需要时间才能赶上,但对于长期投资者来说,这是一个充满希望的机会。</blockquote></p><p> The success of the antiviral is the best illustration yet of Pfizer’s scientific prowess.</p><p><blockquote>抗病毒药物的成功是辉瑞科学实力的最佳例证。</blockquote></p><p> While Pfizer’s Covid-19 vaccine came out of the labs of the German biotech BioNTech (BNTX), the new Covid-19 antiviral was whipped up by what Dolsten called a “dream team” of scientists at Pfizer’s own labs across the Northeast U.S.</p><p><blockquote>虽然辉瑞的新冠肺炎疫苗来自德国生物技术公司BioNTech(BNTX)的实验室,但新的新冠肺炎抗病毒药物是由多尔斯滕所说的辉瑞位于美国东北部实验室的科学家“梦之队”研制出来的。</blockquote></p><p> In the earliest days of the pandemic, Pfizer split its efforts between its collaboration with BioNTech on the vaccine and its quest for a Covid-19 pill. The vaccine effort operated on a huge scale; Dolsten called it a “mega team” that spanned the Atlantic.</p><p><blockquote>在大流行的早期,辉瑞公司将其工作分为与BioNTech在疫苗上的合作和对新冠肺炎药丸的探索。疫苗工作规模巨大;多尔斯滕称之为横跨大西洋的“巨型团队”。</blockquote></p><p> The antiviral project was a much smaller operation—a group of Pfizer experts operating with resources left over from the vaccine push.</p><p><blockquote>抗病毒项目规模要小得多——一组辉瑞专家利用疫苗推广剩余的资源进行运营。</blockquote></p><p> “The small molecule was more like a nimble, laser-focused, high-end team, with rather moderate resources,” Dolsten said.</p><p><blockquote>“小分子更像是一个灵活、专注于激光的高端团队,拥有相当适中的资源,”多尔斯滕说。</blockquote></p><p> Dolsten gathered some of Pfizer’s most experienced scientists to work on the antiviral project, including its head of medicine design, Charlotte Allerton. The scientists started with work Pfizer had done years ago on a type of antiviral called a protease inhibitor.</p><p><blockquote>多尔斯滕召集了辉瑞公司一些最有经验的科学家参与抗病毒项目,其中包括药物设计主管夏洛特·阿勒顿。科学家们从辉瑞公司多年前在一种叫做蛋白酶抑制剂的抗病毒药物上所做的工作开始。</blockquote></p><p> “[Pfizer’s] pharmaceutical R&D is better than people had thought.”</p><p><blockquote>“(辉瑞的)制药研发比人们想象的要好。”</blockquote></p><p> The protease inhibitors in the Pfizer library, however, had been administered intravenously, and had not worked well when delivered orally. The team had to figure out how to adapt the drugs to oral administration, a substantial undertaking.</p><p><blockquote>然而,辉瑞文库中的蛋白酶抑制剂已经静脉内施用,并且当口服递送时效果不佳。该团队必须弄清楚如何使药物适应口服给药,这是一项艰巨的任务。</blockquote></p><p> “They had to really create a lot of new chemistry,” Dolsten said. The scientists created 600 compounds to nail down the right drug, a process that might normally take years, and which they accomplished in a matter of months. “Four years turned into four months here,” he said.</p><p><blockquote>“他们必须真正创造很多新的化学反应,”多尔斯滕说。科学家们创造了600种化合物来确定正确的药物,这个过程通常可能需要数年时间,但他们在几个月内就完成了。“在这里,四年变成了四个月,”他说。</blockquote></p><p> Pfizer started testing the pill in humans in March. It is now running a number of Phase 2/3 trials of the drug, including one for patients who are high risk, one for patients not high risk, and one as a prophylaxis for patients who have been exposed to the virus but aren’t yet sick. In the first readout, the drug looked substantially more effective than the Covid treatment pill from Merck (MRK).</p><p><blockquote>辉瑞公司于三月份开始在人体中测试这种药物。该公司目前正在进行该药物的多项2/3期试验,包括一项针对高风险患者,一项针对非高风险患者,以及一项针对接触过病毒但尚未患病的患者的预防试验。在第一次读数中,该药物看起来比默克公司(MRK)的新冠治疗药物有效得多。</blockquote></p><p> “It definitely helps prove the point that [Pfizer’s] pharmaceutical R&D is better than people had thought,” says Louise Chen, an analyst at Cantor Fitzgerald, who has an Overweight rating and a $61 price target on the stock.</p><p><blockquote>Cantor Fitzgerald分析师Louise Chen表示:“这无疑有助于证明辉瑞的制药研发比人们想象的要好。”她对该股给予跑赢大盘评级,目标价为61美元。</blockquote></p><p></p><p> Chen says that she doesn’t expect investors to come around to her way of thinking until there is more clarity on the durability of Covid-19 vaccine and pill sales, and the rest of the pipeline gets proved out.</p><p><blockquote>陈表示,在Covid-19疫苗和药丸销售的持久性更加明确以及其余产品得到证实之前,她预计投资者不会接受她的想法。</blockquote></p><p> “There is not one event that I think will trigger a re-rating of the stock at the next level,” she says. “Until those things play out, I don’t think that it necessarily will.”</p><p><blockquote>“我认为没有一个事件会引发该股下一个级别的重新评级,”她说。“在这些事情发生之前,我认为不一定会发生。”</blockquote></p><p> That makes a bet on Pfizer a long-term play. In the meantime, the experience of Moderna (MRNA) in recent weeks is highlighting the potential for the vaccine makers to come under scrutiny over unequal distribution of vaccines.</p><p><blockquote>这使得对辉瑞的押注成为一项长期投资。与此同时,Moderna(MRNA)最近几周的经历凸显了疫苗制造商因疫苗分配不平等而受到审查的可能性。</blockquote></p><p> Biden administration officials have been increasingly frustrated with Moderna, calling on the company to ramp up production so it can offer more doses at not-for-profit prices to low-income countries, with one top official calling on the company to “step up.”</p><p><blockquote>拜登政府官员对Moderna越来越失望,呼吁该公司提高产量,以便能够以非营利价格向低收入国家提供更多剂量,一位高级官员呼吁该公司“挺身而出”。</blockquote></p><p> Moderna shares are down more than 40% over the past three months.</p><p><blockquote>Moderna股价在过去三个月下跌了40%以上。</blockquote></p><p> As the pandemic persists, Pfizer risks eroding the enormous goodwill it earned roughly a year ago when it introduced its Covid-19 vaccine. Earlier this month, Pfizer CEO Bourla blamed low-income countries for unfair vaccine distribution, telling <i>Barron’s</i> that it was their fault for not placing orders. Pfizer has sold a billion vaccine doses to the U.S. at a not-for-profit price to donate to poor countries, and says that a total of at least two billion doses will be delivered to low- and middle-income nations by the end of next year.</p><p><blockquote>随着疫情的持续,辉瑞面临着侵蚀大约一年前推出Covid-19疫苗时赢得的巨大商誉的风险。本月早些时候,辉瑞首席执行官布尔拉指责低收入国家疫苗分配不公平,告诉<i>巴伦周刊</i>没有下订单是他们的错。辉瑞公司已以非营利价格向美国出售了10亿剂疫苗,捐赠给贫穷国家,并表示到明年年底将向中低收入国家提供总计至少20亿剂疫苗。</blockquote></p><p> When it comes to antivirals, Pfizer has said only that it will offer tiered pricing for poorer nations, the same approach it has taken with its vaccine.</p><p><blockquote>在抗病毒药物方面,辉瑞仅表示将为较贫穷国家提供分级定价,与其疫苗采用的方法相同。</blockquote></p><p> That contrasts sharply with Merck’s plan to make its own Covid-19 pill available to poor countries. Merck has signed a deal with a United Nations-backed group that will allow its pill to be licensed globally, with no royalties paid to Merck.</p><p><blockquote>这与默克公司向贫穷国家提供自己的Covid-19药丸的计划形成鲜明对比。默克公司已与一个联合国支持的组织签署了一项协议,允许其药丸在全球范围内获得许可,无需向默克公司支付特许权使用费。</blockquote></p><p> Dolsten said that Pfizer is looking into licensing its pill under a similar mechanism as Merck’s. “We will look at those options,” he said. “By no means have we said we would do something different. We just want to make sure whoever will be involved gets the advice and skill to do this.”</p><p><blockquote>多尔斯滕表示,辉瑞正在考虑根据与默克类似的机制许可其药物。“我们将考虑这些选择,”他说。“我们绝不是说我们会做一些不同的事情。我们只是想确保参与其中的人都能获得这样做的建议和技能。”</blockquote></p><p> Such a step couldn’t come soon enough. Late last month, activists protested outside Bourla’s home, calling on Pfizer to share its vaccine manufacturing technology and to fill orders from low-income countries ahead of those from wealthy countries.</p><p><blockquote>这样的一步来得太快了。上月底,活动人士在布尔拉家外抗议,呼吁辉瑞分享其疫苗制造技术,并在富裕国家之前完成低收入国家的订单。</blockquote></p><p> An aggressive plan to share its antiviral would help stave off such criticism, keeping Pfizer in the relative good graces of Washington and allowing its impressive science to continue to drive the stock higher.</p><p><blockquote>分享其抗病毒药物的积极计划将有助于避免此类批评,使辉瑞公司相对受到华盛顿的青睐,并使其令人印象深刻的科学知识继续推动股价走高。</blockquote></p><p></p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer Shows Its R&D Is Strong. It’s a Good Sign for the Stock.<blockquote>辉瑞显示其研发实力雄厚。这对该股来说是一个好兆头。</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer Shows Its R&D Is Strong. It’s a Good Sign for the Stock.<blockquote>辉瑞显示其研发实力雄厚。这对该股来说是一个好兆头。</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Barrons</strong><span class=\"h-time small\">2021-11-13 11:00</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Pfizer’s chief scientific officer, Mikael Dolsten, sounded giddy when reached via telephone early Monday morning. It was just days after his company knocked the socks off the market with the news that its Covid-19 antiviral had cut the risk of hospitalization by 89% in high-risk adults.</p><p><blockquote>周一早上,辉瑞公司首席科学官米凯尔·多尔斯滕(Mikael Dolsten)接到电话时,听起来很头晕。就在几天前,他的公司宣布其Covid-19抗病毒药物将高危成年人的住院风险降低了89%。</blockquote></p><p> “It can’t be just a random thing, that you’re able to beat this type of world record and get a grand slam at the same time by chance,” Dolsten said, scrambling sports metaphors as he sought to illustrate the magnitude of Pfizer’s twin wins: the development of a stunningly effective Covid-19 vaccine in just 10 months, followed a year later by the development of a similarly stunning Covid-19 antiviral.</p><p><blockquote>多尔斯滕说:“你能够打破这种类型的世界纪录,同时偶然获得大满贯,这不可能只是一件随机的事情。”他在试图说明辉瑞的双重胜利:在短短10个月内开发出了一种效果惊人的Covid-19疫苗,一年后又开发出了一种同样令人惊叹的Covid-19抗病毒药物。</blockquote></p><p> Two years ago, Pfizer (ticker: PFE) CEO Albert Bourla asked investors to take a big gamble on the research-and-development operation that Dolsten has rebuilt over the course of more than a decade. That bet is looking smarter than ever.</p><p><blockquote>两年前,辉瑞(股票代码:PFE)首席执行官阿尔伯特·布尔拉(Albert Bourla)要求投资者对多尔斯滕十多年来重建的研发业务进行豪赌。这个赌注看起来比以往任何时候都更聪明。</blockquote></p><p> Bourla has gotten rid of Pfizer’s off-patent drugs division and the last of its consumer health products, leaving behind a pure-play biopharma company that will live or die on the strength of Dolsten’s science.</p><p><blockquote>Bourla已经摆脱了辉瑞的非专利药物部门及其最后的消费者健康产品,留下了一家纯粹的生物制药公司,该公司的生死存亡都取决于Dolsten的科学实力。</blockquote></p><p> In a cover story in November 2019, <i>Barron’s</i> argued that Bourla and Dolsten could pull it off.</p><p><blockquote>在2019年11月的一篇封面报道中,<i>巴伦周刊</i>认为布尔拉和多尔斯滕可以成功。</blockquote></p><p> The new antiviral data reaffirms the case for Pfizer that <i>Barron’s</i> made two years ago. Continuing to profit off the pandemic, however, brings new risks, as criticism grows over the global inequity in vaccine distribution. Low-income nations account for less than 1% of the more than seven billion doses administered worldwide. If distribution of Pfizer’s antiviral continues to favor wealthy nations, the company’s stock could ultimately suffer.</p><p><blockquote>新的抗病毒数据再次证实了辉瑞的理由<i>巴伦周刊</i>两年前做的。然而,随着对全球疫苗分配不平等的批评越来越多,继续从大流行中获利会带来新的风险。在全球超过70亿剂疫苗中,低收入国家仅占不到1%。如果辉瑞抗病毒药物的分销继续有利于富裕国家,该公司的股票最终可能会受到影响。</blockquote></p><p> Pfizer’s shares surged 10.9% the day the data came out, their best daily showing in at least 20 years. Still, with the stock now changing hands at around $50, investors continue to undervalue the company. Investors are pricing Pfizer at 12 times next year’s expected earnings, cheaper than peers like Johnson & Johnson (JNJ) and Eli Lilly (LLY).</p><p><blockquote>数据公布当天,辉瑞股价飙升10.9%,创下至少20年来的最佳单日表现。尽管如此,由于该股目前易手价格约为50美元,投资者继续低估该公司的价值。投资者对辉瑞的定价是明年预期收益的12倍,低于强生(JNJ)和礼来(LLY)等同行。</blockquote></p><p> The Pfizer discount can be attributed to concerns over the patent cliff the drugmaker faces at the end of the decade. The company stands to lose exclusivity over a handful of drugs that bring in billions in annual revenue.</p><p><blockquote>辉瑞的折扣可归因于对该制药商在本世纪末面临专利悬崖的担忧。该公司将失去对少数年收入数十亿美元的药物的独家经营权。</blockquote></p><p> The worries are legitimate, but Pfizer’s scientific coup should give investors confidence that the company’s science can carry it safely over that cliff. It may take time for the market to catch up, but for long-term investors, it’s a promising opportunity.</p><p><blockquote>这些担忧是合理的,但辉瑞的科学政变应该让投资者相信该公司的科学能够安全地越过悬崖。市场可能需要时间才能赶上,但对于长期投资者来说,这是一个充满希望的机会。</blockquote></p><p> The success of the antiviral is the best illustration yet of Pfizer’s scientific prowess.</p><p><blockquote>抗病毒药物的成功是辉瑞科学实力的最佳例证。</blockquote></p><p> While Pfizer’s Covid-19 vaccine came out of the labs of the German biotech BioNTech (BNTX), the new Covid-19 antiviral was whipped up by what Dolsten called a “dream team” of scientists at Pfizer’s own labs across the Northeast U.S.</p><p><blockquote>虽然辉瑞的新冠肺炎疫苗来自德国生物技术公司BioNTech(BNTX)的实验室,但新的新冠肺炎抗病毒药物是由多尔斯滕所说的辉瑞位于美国东北部实验室的科学家“梦之队”研制出来的。</blockquote></p><p> In the earliest days of the pandemic, Pfizer split its efforts between its collaboration with BioNTech on the vaccine and its quest for a Covid-19 pill. The vaccine effort operated on a huge scale; Dolsten called it a “mega team” that spanned the Atlantic.</p><p><blockquote>在大流行的早期,辉瑞公司将其工作分为与BioNTech在疫苗上的合作和对新冠肺炎药丸的探索。疫苗工作规模巨大;多尔斯滕称之为横跨大西洋的“巨型团队”。</blockquote></p><p> The antiviral project was a much smaller operation—a group of Pfizer experts operating with resources left over from the vaccine push.</p><p><blockquote>抗病毒项目规模要小得多——一组辉瑞专家利用疫苗推广剩余的资源进行运营。</blockquote></p><p> “The small molecule was more like a nimble, laser-focused, high-end team, with rather moderate resources,” Dolsten said.</p><p><blockquote>“小分子更像是一个灵活、专注于激光的高端团队,拥有相当适中的资源,”多尔斯滕说。</blockquote></p><p> Dolsten gathered some of Pfizer’s most experienced scientists to work on the antiviral project, including its head of medicine design, Charlotte Allerton. The scientists started with work Pfizer had done years ago on a type of antiviral called a protease inhibitor.</p><p><blockquote>多尔斯滕召集了辉瑞公司一些最有经验的科学家参与抗病毒项目,其中包括药物设计主管夏洛特·阿勒顿。科学家们从辉瑞公司多年前在一种叫做蛋白酶抑制剂的抗病毒药物上所做的工作开始。</blockquote></p><p> “[Pfizer’s] pharmaceutical R&D is better than people had thought.”</p><p><blockquote>“(辉瑞的)制药研发比人们想象的要好。”</blockquote></p><p> The protease inhibitors in the Pfizer library, however, had been administered intravenously, and had not worked well when delivered orally. The team had to figure out how to adapt the drugs to oral administration, a substantial undertaking.</p><p><blockquote>然而,辉瑞文库中的蛋白酶抑制剂已经静脉内施用,并且当口服递送时效果不佳。该团队必须弄清楚如何使药物适应口服给药,这是一项艰巨的任务。</blockquote></p><p> “They had to really create a lot of new chemistry,” Dolsten said. The scientists created 600 compounds to nail down the right drug, a process that might normally take years, and which they accomplished in a matter of months. “Four years turned into four months here,” he said.</p><p><blockquote>“他们必须真正创造很多新的化学反应,”多尔斯滕说。科学家们创造了600种化合物来确定正确的药物,这个过程通常可能需要数年时间,但他们在几个月内就完成了。“在这里,四年变成了四个月,”他说。</blockquote></p><p> Pfizer started testing the pill in humans in March. It is now running a number of Phase 2/3 trials of the drug, including one for patients who are high risk, one for patients not high risk, and one as a prophylaxis for patients who have been exposed to the virus but aren’t yet sick. In the first readout, the drug looked substantially more effective than the Covid treatment pill from Merck (MRK).</p><p><blockquote>辉瑞公司于三月份开始在人体中测试这种药物。该公司目前正在进行该药物的多项2/3期试验,包括一项针对高风险患者,一项针对非高风险患者,以及一项针对接触过病毒但尚未患病的患者的预防试验。在第一次读数中,该药物看起来比默克公司(MRK)的新冠治疗药物有效得多。</blockquote></p><p> “It definitely helps prove the point that [Pfizer’s] pharmaceutical R&D is better than people had thought,” says Louise Chen, an analyst at Cantor Fitzgerald, who has an Overweight rating and a $61 price target on the stock.</p><p><blockquote>Cantor Fitzgerald分析师Louise Chen表示:“这无疑有助于证明辉瑞的制药研发比人们想象的要好。”她对该股给予跑赢大盘评级,目标价为61美元。</blockquote></p><p></p><p> Chen says that she doesn’t expect investors to come around to her way of thinking until there is more clarity on the durability of Covid-19 vaccine and pill sales, and the rest of the pipeline gets proved out.</p><p><blockquote>陈表示,在Covid-19疫苗和药丸销售的持久性更加明确以及其余产品得到证实之前,她预计投资者不会接受她的想法。</blockquote></p><p> “There is not one event that I think will trigger a re-rating of the stock at the next level,” she says. “Until those things play out, I don’t think that it necessarily will.”</p><p><blockquote>“我认为没有一个事件会引发该股下一个级别的重新评级,”她说。“在这些事情发生之前,我认为不一定会发生。”</blockquote></p><p> That makes a bet on Pfizer a long-term play. In the meantime, the experience of Moderna (MRNA) in recent weeks is highlighting the potential for the vaccine makers to come under scrutiny over unequal distribution of vaccines.</p><p><blockquote>这使得对辉瑞的押注成为一项长期投资。与此同时,Moderna(MRNA)最近几周的经历凸显了疫苗制造商因疫苗分配不平等而受到审查的可能性。</blockquote></p><p> Biden administration officials have been increasingly frustrated with Moderna, calling on the company to ramp up production so it can offer more doses at not-for-profit prices to low-income countries, with one top official calling on the company to “step up.”</p><p><blockquote>拜登政府官员对Moderna越来越失望,呼吁该公司提高产量,以便能够以非营利价格向低收入国家提供更多剂量,一位高级官员呼吁该公司“挺身而出”。</blockquote></p><p> Moderna shares are down more than 40% over the past three months.</p><p><blockquote>Moderna股价在过去三个月下跌了40%以上。</blockquote></p><p> As the pandemic persists, Pfizer risks eroding the enormous goodwill it earned roughly a year ago when it introduced its Covid-19 vaccine. Earlier this month, Pfizer CEO Bourla blamed low-income countries for unfair vaccine distribution, telling <i>Barron’s</i> that it was their fault for not placing orders. Pfizer has sold a billion vaccine doses to the U.S. at a not-for-profit price to donate to poor countries, and says that a total of at least two billion doses will be delivered to low- and middle-income nations by the end of next year.</p><p><blockquote>随着疫情的持续,辉瑞面临着侵蚀大约一年前推出Covid-19疫苗时赢得的巨大商誉的风险。本月早些时候,辉瑞首席执行官布尔拉指责低收入国家疫苗分配不公平,告诉<i>巴伦周刊</i>没有下订单是他们的错。辉瑞公司已以非营利价格向美国出售了10亿剂疫苗,捐赠给贫穷国家,并表示到明年年底将向中低收入国家提供总计至少20亿剂疫苗。</blockquote></p><p> When it comes to antivirals, Pfizer has said only that it will offer tiered pricing for poorer nations, the same approach it has taken with its vaccine.</p><p><blockquote>在抗病毒药物方面,辉瑞仅表示将为较贫穷国家提供分级定价,与其疫苗采用的方法相同。</blockquote></p><p> That contrasts sharply with Merck’s plan to make its own Covid-19 pill available to poor countries. Merck has signed a deal with a United Nations-backed group that will allow its pill to be licensed globally, with no royalties paid to Merck.</p><p><blockquote>这与默克公司向贫穷国家提供自己的Covid-19药丸的计划形成鲜明对比。默克公司已与一个联合国支持的组织签署了一项协议,允许其药丸在全球范围内获得许可,无需向默克公司支付特许权使用费。</blockquote></p><p> Dolsten said that Pfizer is looking into licensing its pill under a similar mechanism as Merck’s. “We will look at those options,” he said. “By no means have we said we would do something different. We just want to make sure whoever will be involved gets the advice and skill to do this.”</p><p><blockquote>多尔斯滕表示,辉瑞正在考虑根据与默克类似的机制许可其药物。“我们将考虑这些选择,”他说。“我们绝不是说我们会做一些不同的事情。我们只是想确保参与其中的人都能获得这样做的建议和技能。”</blockquote></p><p> Such a step couldn’t come soon enough. Late last month, activists protested outside Bourla’s home, calling on Pfizer to share its vaccine manufacturing technology and to fill orders from low-income countries ahead of those from wealthy countries.</p><p><blockquote>这样的一步来得太快了。上月底,活动人士在布尔拉家外抗议,呼吁辉瑞分享其疫苗制造技术,并在富裕国家之前完成低收入国家的订单。</blockquote></p><p> An aggressive plan to share its antiviral would help stave off such criticism, keeping Pfizer in the relative good graces of Washington and allowing its impressive science to continue to drive the stock higher.</p><p><blockquote>分享其抗病毒药物的积极计划将有助于避免此类批评,使辉瑞公司相对受到华盛顿的青睐,并使其令人印象深刻的科学知识继续推动股价走高。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源:<a href=\"https://www.barrons.com/articles/buy-pfizer-stock-covid-19-51636674652?mod=hp_LEAD_1\">Barrons</a></p>\n<p>为提升您的阅读体验,我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://www.barrons.com/articles/buy-pfizer-stock-covid-19-51636674652?mod=hp_LEAD_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1102251183","content_text":"Pfizer’s chief scientific officer, Mikael Dolsten, sounded giddy when reached via telephone early Monday morning. It was just days after his company knocked the socks off the market with the news that its Covid-19 antiviral had cut the risk of hospitalization by 89% in high-risk adults.\n“It can’t be just a random thing, that you’re able to beat this type of world record and get a grand slam at the same time by chance,” Dolsten said, scrambling sports metaphors as he sought to illustrate the magnitude of Pfizer’s twin wins: the development of a stunningly effective Covid-19 vaccine in just 10 months, followed a year later by the development of a similarly stunning Covid-19 antiviral.\nTwo years ago, Pfizer (ticker: PFE) CEO Albert Bourla asked investors to take a big gamble on the research-and-development operation that Dolsten has rebuilt over the course of more than a decade. That bet is looking smarter than ever.\nBourla has gotten rid of Pfizer’s off-patent drugs division and the last of its consumer health products, leaving behind a pure-play biopharma company that will live or die on the strength of Dolsten’s science.\nIn a cover story in November 2019, Barron’s argued that Bourla and Dolsten could pull it off.\nThe new antiviral data reaffirms the case for Pfizer that Barron’s made two years ago. Continuing to profit off the pandemic, however, brings new risks, as criticism grows over the global inequity in vaccine distribution. Low-income nations account for less than 1% of the more than seven billion doses administered worldwide. If distribution of Pfizer’s antiviral continues to favor wealthy nations, the company’s stock could ultimately suffer.\nPfizer’s shares surged 10.9% the day the data came out, their best daily showing in at least 20 years. Still, with the stock now changing hands at around $50, investors continue to undervalue the company. Investors are pricing Pfizer at 12 times next year’s expected earnings, cheaper than peers like Johnson & Johnson (JNJ) and Eli Lilly (LLY).\nThe Pfizer discount can be attributed to concerns over the patent cliff the drugmaker faces at the end of the decade. The company stands to lose exclusivity over a handful of drugs that bring in billions in annual revenue.\nThe worries are legitimate, but Pfizer’s scientific coup should give investors confidence that the company’s science can carry it safely over that cliff. It may take time for the market to catch up, but for long-term investors, it’s a promising opportunity.\nThe success of the antiviral is the best illustration yet of Pfizer’s scientific prowess.\nWhile Pfizer’s Covid-19 vaccine came out of the labs of the German biotech BioNTech (BNTX), the new Covid-19 antiviral was whipped up by what Dolsten called a “dream team” of scientists at Pfizer’s own labs across the Northeast U.S.\nIn the earliest days of the pandemic, Pfizer split its efforts between its collaboration with BioNTech on the vaccine and its quest for a Covid-19 pill. The vaccine effort operated on a huge scale; Dolsten called it a “mega team” that spanned the Atlantic.\nThe antiviral project was a much smaller operation—a group of Pfizer experts operating with resources left over from the vaccine push.\n“The small molecule was more like a nimble, laser-focused, high-end team, with rather moderate resources,” Dolsten said.\nDolsten gathered some of Pfizer’s most experienced scientists to work on the antiviral project, including its head of medicine design, Charlotte Allerton. The scientists started with work Pfizer had done years ago on a type of antiviral called a protease inhibitor.\n“[Pfizer’s] pharmaceutical R&D is better than people had thought.”\nThe protease inhibitors in the Pfizer library, however, had been administered intravenously, and had not worked well when delivered orally. The team had to figure out how to adapt the drugs to oral administration, a substantial undertaking.\n“They had to really create a lot of new chemistry,” Dolsten said. The scientists created 600 compounds to nail down the right drug, a process that might normally take years, and which they accomplished in a matter of months. “Four years turned into four months here,” he said.\nPfizer started testing the pill in humans in March. It is now running a number of Phase 2/3 trials of the drug, including one for patients who are high risk, one for patients not high risk, and one as a prophylaxis for patients who have been exposed to the virus but aren’t yet sick. In the first readout, the drug looked substantially more effective than the Covid treatment pill from Merck (MRK).\n“It definitely helps prove the point that [Pfizer’s] pharmaceutical R&D is better than people had thought,” says Louise Chen, an analyst at Cantor Fitzgerald, who has an Overweight rating and a $61 price target on the stock.\nChen says that she doesn’t expect investors to come around to her way of thinking until there is more clarity on the durability of Covid-19 vaccine and pill sales, and the rest of the pipeline gets proved out.\n“There is not one event that I think will trigger a re-rating of the stock at the next level,” she says. “Until those things play out, I don’t think that it necessarily will.”\nThat makes a bet on Pfizer a long-term play. In the meantime, the experience of Moderna (MRNA) in recent weeks is highlighting the potential for the vaccine makers to come under scrutiny over unequal distribution of vaccines.\nBiden administration officials have been increasingly frustrated with Moderna, calling on the company to ramp up production so it can offer more doses at not-for-profit prices to low-income countries, with one top official calling on the company to “step up.”\nModerna shares are down more than 40% over the past three months.\nAs the pandemic persists, Pfizer risks eroding the enormous goodwill it earned roughly a year ago when it introduced its Covid-19 vaccine. Earlier this month, Pfizer CEO Bourla blamed low-income countries for unfair vaccine distribution, telling Barron’s that it was their fault for not placing orders. Pfizer has sold a billion vaccine doses to the U.S. at a not-for-profit price to donate to poor countries, and says that a total of at least two billion doses will be delivered to low- and middle-income nations by the end of next year.\nWhen it comes to antivirals, Pfizer has said only that it will offer tiered pricing for poorer nations, the same approach it has taken with its vaccine.\nThat contrasts sharply with Merck’s plan to make its own Covid-19 pill available to poor countries. Merck has signed a deal with a United Nations-backed group that will allow its pill to be licensed globally, with no royalties paid to Merck.\nDolsten said that Pfizer is looking into licensing its pill under a similar mechanism as Merck’s. “We will look at those options,” he said. “By no means have we said we would do something different. We just want to make sure whoever will be involved gets the advice and skill to do this.”\nSuch a step couldn’t come soon enough. Late last month, activists protested outside Bourla’s home, calling on Pfizer to share its vaccine manufacturing technology and to fill orders from low-income countries ahead of those from wealthy countries.\nAn aggressive plan to share its antiviral would help stave off such criticism, keeping Pfizer in the relative good graces of Washington and allowing its impressive science to continue to drive the stock higher.","news_type":1,"symbols_score_info":{"PFE":0.9}},"isVote":1,"tweetType":1,"viewCount":2796,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":870165024,"gmtCreate":1636594128298,"gmtModify":1636594128422,"author":{"id":"3581894830339885","authorId":"3581894830339885","name":"Desmondsim","avatar":"https://static.tigerbbs.com/9484cf4599b477a3985c44fe04da87b3","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581894830339885","idStr":"3581894830339885"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/870165024","repostId":"2182058925","repostType":4,"isVote":1,"tweetType":1,"viewCount":3077,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":844515908,"gmtCreate":1636439839392,"gmtModify":1636439839669,"author":{"id":"3581894830339885","authorId":"3581894830339885","name":"Desmondsim","avatar":"https://static.tigerbbs.com/9484cf4599b477a3985c44fe04da87b3","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581894830339885","idStr":"3581894830339885"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>Nicee","listText":"<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>Nicee","text":"$Apple(AAPL)$Nicee","images":[{"img":"https://static.tigerbbs.com/3d6d8fbcfe53ce305f7940cb7f90cd39","width":"1125","height":"2196"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/844515908","isVote":1,"tweetType":1,"viewCount":3255,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":844515048,"gmtCreate":1636439818102,"gmtModify":1636439818385,"author":{"id":"3581894830339885","authorId":"3581894830339885","name":"Desmondsim","avatar":"https://static.tigerbbs.com/9484cf4599b477a3985c44fe04da87b3","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581894830339885","idStr":"3581894830339885"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ETSY\">$Etsy(ETSY)$</a>Nicee","listText":"<a href=\"https://laohu8.com/S/ETSY\">$Etsy(ETSY)$</a>Nicee","text":"$Etsy(ETSY)$Nicee","images":[{"img":"https://static.tigerbbs.com/fa7bc8a8d36c18ca397636558b67dcb4","width":"1125","height":"2983"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/844515048","isVote":1,"tweetType":1,"viewCount":3727,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":845223086,"gmtCreate":1636343072567,"gmtModify":1636343072838,"author":{"id":"3581894830339885","authorId":"3581894830339885","name":"Desmondsim","avatar":"https://static.tigerbbs.com/9484cf4599b477a3985c44fe04da87b3","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581894830339885","idStr":"3581894830339885"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/845223086","repostId":"2181728933","repostType":4,"isVote":1,"tweetType":1,"viewCount":2056,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":845229617,"gmtCreate":1636343051520,"gmtModify":1636343051801,"author":{"id":"3581894830339885","authorId":"3581894830339885","name":"Desmondsim","avatar":"https://static.tigerbbs.com/9484cf4599b477a3985c44fe04da87b3","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581894830339885","idStr":"3581894830339885"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>Nicee","listText":"<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>Nicee","text":"$Apple(AAPL)$Nicee","images":[{"img":"https://static.tigerbbs.com/06e7cf1574d5e5ead4e59c08462fcdfc","width":"1125","height":"2196"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/845229617","isVote":1,"tweetType":1,"viewCount":451,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":845229197,"gmtCreate":1636343037711,"gmtModify":1636343038001,"author":{"id":"3581894830339885","authorId":"3581894830339885","name":"Desmondsim","avatar":"https://static.tigerbbs.com/9484cf4599b477a3985c44fe04da87b3","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581894830339885","idStr":"3581894830339885"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ETSY\">$Etsy(ETSY)$</a>Nicee","listText":"<a href=\"https://laohu8.com/S/ETSY\">$Etsy(ETSY)$</a>Nicee","text":"$Etsy(ETSY)$Nicee","images":[{"img":"https://static.tigerbbs.com/7e8fc03ab34016236f566b76a248b308","width":"1125","height":"2983"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/845229197","isVote":1,"tweetType":1,"viewCount":604,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":842631850,"gmtCreate":1636168112042,"gmtModify":1636168112344,"author":{"id":"3581894830339885","authorId":"3581894830339885","name":"Desmondsim","avatar":"https://static.tigerbbs.com/9484cf4599b477a3985c44fe04da87b3","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581894830339885","idStr":"3581894830339885"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/842631850","repostId":"1173813098","repostType":4,"isVote":1,"tweetType":1,"viewCount":436,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":842631353,"gmtCreate":1636168092163,"gmtModify":1636168092443,"author":{"id":"3581894830339885","authorId":"3581894830339885","name":"Desmondsim","avatar":"https://static.tigerbbs.com/9484cf4599b477a3985c44fe04da87b3","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581894830339885","idStr":"3581894830339885"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>Nicee","listText":"<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>Nicee","text":"$Apple(AAPL)$Nicee","images":[{"img":"https://static.tigerbbs.com/06e7cf1574d5e5ead4e59c08462fcdfc","width":"1125","height":"2196"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/842631353","isVote":1,"tweetType":1,"viewCount":464,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":846230385,"gmtCreate":1636084129314,"gmtModify":1636084129557,"author":{"id":"3581894830339885","authorId":"3581894830339885","name":"Desmondsim","avatar":"https://static.tigerbbs.com/9484cf4599b477a3985c44fe04da87b3","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581894830339885","idStr":"3581894830339885"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/846230385","repostId":"1128227989","repostType":4,"repost":{"id":"1128227989","kind":"news","pubTimestamp":1636067303,"share":"https://www.laohu8.com/m/news/1128227989?lang=zh_CN&edition=full","pubTime":"2021-11-05 07:08","market":"us","language":"en","title":"S&P 500, Nasdaq extend record streaks, with boost from chip, growth shares<blockquote>在芯片和成长股的推动下,标普500和纳斯达克延续了创纪录的连胜纪录</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1128227989","media":"Reuters","summary":" - The S&P 500 and Nasdaq rose on Thursday, extending their streaks of record high closes to six sessions, as chipmaker stocks surged following Qualcomm’s strong financial forecast and investors digested the Federal Reserve’s decision to start reducing its monthly bond purchases.The Dow Jones Industrial Average posted a slim loss, ending its streak of record closes at four. Declines in shares of banks JPMorgan Chase & Co and Goldman Sachs Group weighed on the blue-chip index.Financials dropped 1","content":"<p>(Reuters) - The S&P 500 and Nasdaq rose on Thursday, extending their streaks of record high closes to six sessions, as chipmaker stocks surged following Qualcomm’s strong financial forecast and investors digested the Federal Reserve’s decision to start reducing its monthly bond purchases.</p><p><blockquote>(路透社)-标普500和纳斯达克周四上涨,将收盘纪录高位连涨至六个交易日,因高通强劲的财务预测以及投资者消化了美联储开始减少月度债券购买的决定后,芯片制造商股市飙升。</blockquote></p><p> The Dow Jones Industrial Average posted a slim loss, ending its streak of record closes at four. Declines in shares of banks JPMorgan Chase & Co and Goldman Sachs Group weighed on the blue-chip index.</p><p><blockquote>道琼斯工业平均指数小幅下跌,结束了四点收盘的纪录。摩根大通和高盛集团银行股的下跌打压了蓝筹股指数。</blockquote></p><p> Financials dropped 1.3%, most among S&P 500 sectors, as U.S. Treasury yields fell, with the market unwinding expectations of quicker Fed rate hikes a day after the central bank signaled it was in no hurry to do so.</p><p><blockquote>金融股下跌1.3%,其中大部分是标普500板块,因美国国债收益率下跌,在美联储表示不急于加息的第二天,市场解除了对美联储更快加息的预期。</blockquote></p><p> “The growth side of the market is seeing more positive results today as they are benefiting from the falling yields that are developing,” said Matthew Miskin, co-chief investment strategist at John Hancock Investment Management.</p><p><blockquote>John Hancock Investment Management联席首席投资策略师马修·米斯金(Matthew Miskin)表示:“市场的增长方今天看到了更积极的结果,因为它们受益于收益率的下降。”</blockquote></p><p> “The market had been positioning for higher yields in general given the Fed announcement of tapering. As we walked in today, there has been a reversal in that.”</p><p><blockquote>“鉴于美联储宣布缩减规模,市场总体上一直在为更高的收益率做准备。当我们今天走进来时,这种情况已经发生了逆转。”</blockquote></p><p> The Dow Jones Industrial Average fell 33.35 points, or 0.09%, to 36,124.23, the S&P 500 gained 19.49 points, or 0.42%, to 4,680.06 and the Nasdaq Composite added 128.72 points, or 0.81%, to 15,940.31.</p><p><blockquote>道琼斯工业平均指数下跌33.35点,跌幅0.09%,至36,124.23点;标普500上涨19.49点,跌幅0.42%,至4,680.06点;纳斯达克综合指数上涨128.72点,跌幅0.81%,至15,940.31点。</blockquote></p><p> The S&P 500 growth index rose 1.2% while the S&P 500 value index fell 0.5%.</p><p><blockquote>标普500增长指数上涨1.2%,标普500价值指数下跌0.5%。</blockquote></p><p> Among S&P 500 sectors, tech and consumer discretionary led the way, both rising about 1.5%.</p><p><blockquote>标普500板块中,科技和非必需消费品领涨,均上涨约1.5%。</blockquote></p><p> Qualcomm shares jumped 12.7% as the company forecast better-than-expected profits and revenue for its current quarter on soaring demand for chips used in phones, cars and other internet-connected devices.</p><p><blockquote>高通股价上涨12.7%,该公司预测本季度利润和收入好于预期,原因是手机、汽车和其他互联网连接设备所用芯片的需求飙升。</blockquote></p><p> The Philadelphia SE Semiconductor index climbed 3.5%, with Nvidia soaring 12%.</p><p><blockquote>费城SE半导体指数上涨3.5%,英伟达飙升12%。</blockquote></p><p> Better-than-expected third-quarter earnings have helped lift sentiment for equities. With about 420 companies having reported, S&P 500 earnings are expected to have climbed 41.2% in the third quarter from a year earlier, according to Refinitiv IBES.</p><p><blockquote>好于预期的第三季度收益有助于提振股市情绪。根据Refinitiv IBES的数据,约有420家公司发布了财报,预计标普500第三季度盈利将同比增长41.2%。</blockquote></p><p> “The corporate earnings story remains quite bright,” said Craig Fehr, investment strategist at Edward Jones.</p><p><blockquote>爱德华·琼斯投资策略师克雷格·费尔表示:“企业盈利情况仍然相当光明。”</blockquote></p><p> “The market is rewarding companies that are beating and upping their outlook, and the market is punishing companies that are missing their estimates in the quarter and more importantly, perhaps, signaling a more sour outlook.”</p><p><blockquote>“市场正在奖励那些超出预期并上调前景的公司,而市场正在惩罚那些本季度未达到预期的公司,也许更重要的是,这预示着前景更加糟糕。”</blockquote></p><p> Moderna shares tumbled about 18% as the company slashed the 2021 sales forecast for its COVID-19 vaccine by as much as $5 billion, grappling to fill vials and distribute them to meet unprecedented world demand. Moderna shares weighed on the S&P 500 healthcare sector, which fell 0.8%.</p><p><blockquote>Moderna股价暴跌约18%,该公司将其COVID-19疫苗2021年的销售预测削减了多达50亿美元,并努力灌装和分销小瓶,以满足前所未有的全球需求。Moderna股价拖累标普500医疗保健板块,该板块下跌0.8%。</blockquote></p><p> Data showed the number of Americans filing new claims for unemployment benefits fell to the lowest level in nearly 20 months last week, suggesting the economy was regaining momentum. Investors will get a critical view of the economy with the monthly jobs report on Friday.</p><p><blockquote>数据显示,上周美国新申请失业救济人数降至近20个月来的最低水平,表明经济正在恢复动力。投资者将从周五的月度就业报告中获得对经济的批判性看法。</blockquote></p><p> Declining issues outnumbered advancing ones on the NYSE by a 1.12-to-1 ratio; on Nasdaq, a 1.24-to-1 ratio favored decliners.</p><p><blockquote>纽约证券交易所下跌股与上涨股的比例为1.12比1;在纳斯达克,1.24比1的比率有利于下跌股。</blockquote></p><p> The S&P 500 posted 75 new 52-week highs and five new lows; the Nasdaq Composite recorded 224 new highs and 38 new lows.</p><p><blockquote>标普500创下75个52周新高和5个新低;纳斯达克综合指数录得224个新高和38个新低。</blockquote></p><p> About 11.3 billion shares changed hands in U.S. exchanges, above the 10.4 billion daily average over the last 20 sessions.</p><p><blockquote>美国交易所约有113亿股易手,高于过去20个交易日104亿股的日均水平。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>S&P 500, Nasdaq extend record streaks, with boost from chip, growth shares<blockquote>在芯片和成长股的推动下,标普500和纳斯达克延续了创纪录的连胜纪录</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nS&P 500, Nasdaq extend record streaks, with boost from chip, growth shares<blockquote>在芯片和成长股的推动下,标普500和纳斯达克延续了创纪录的连胜纪录</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Reuters</strong><span class=\"h-time small\">2021-11-05 07:08</span>\n</p>\n</h4>\n</header>\n<article>\n<p>(Reuters) - The S&P 500 and Nasdaq rose on Thursday, extending their streaks of record high closes to six sessions, as chipmaker stocks surged following Qualcomm’s strong financial forecast and investors digested the Federal Reserve’s decision to start reducing its monthly bond purchases.</p><p><blockquote>(路透社)-标普500和纳斯达克周四上涨,将收盘纪录高位连涨至六个交易日,因高通强劲的财务预测以及投资者消化了美联储开始减少月度债券购买的决定后,芯片制造商股市飙升。</blockquote></p><p> The Dow Jones Industrial Average posted a slim loss, ending its streak of record closes at four. Declines in shares of banks JPMorgan Chase & Co and Goldman Sachs Group weighed on the blue-chip index.</p><p><blockquote>道琼斯工业平均指数小幅下跌,结束了四点收盘的纪录。摩根大通和高盛集团银行股的下跌打压了蓝筹股指数。</blockquote></p><p> Financials dropped 1.3%, most among S&P 500 sectors, as U.S. Treasury yields fell, with the market unwinding expectations of quicker Fed rate hikes a day after the central bank signaled it was in no hurry to do so.</p><p><blockquote>金融股下跌1.3%,其中大部分是标普500板块,因美国国债收益率下跌,在美联储表示不急于加息的第二天,市场解除了对美联储更快加息的预期。</blockquote></p><p> “The growth side of the market is seeing more positive results today as they are benefiting from the falling yields that are developing,” said Matthew Miskin, co-chief investment strategist at John Hancock Investment Management.</p><p><blockquote>John Hancock Investment Management联席首席投资策略师马修·米斯金(Matthew Miskin)表示:“市场的增长方今天看到了更积极的结果,因为它们受益于收益率的下降。”</blockquote></p><p> “The market had been positioning for higher yields in general given the Fed announcement of tapering. As we walked in today, there has been a reversal in that.”</p><p><blockquote>“鉴于美联储宣布缩减规模,市场总体上一直在为更高的收益率做准备。当我们今天走进来时,这种情况已经发生了逆转。”</blockquote></p><p> The Dow Jones Industrial Average fell 33.35 points, or 0.09%, to 36,124.23, the S&P 500 gained 19.49 points, or 0.42%, to 4,680.06 and the Nasdaq Composite added 128.72 points, or 0.81%, to 15,940.31.</p><p><blockquote>道琼斯工业平均指数下跌33.35点,跌幅0.09%,至36,124.23点;标普500上涨19.49点,跌幅0.42%,至4,680.06点;纳斯达克综合指数上涨128.72点,跌幅0.81%,至15,940.31点。</blockquote></p><p> The S&P 500 growth index rose 1.2% while the S&P 500 value index fell 0.5%.</p><p><blockquote>标普500增长指数上涨1.2%,标普500价值指数下跌0.5%。</blockquote></p><p> Among S&P 500 sectors, tech and consumer discretionary led the way, both rising about 1.5%.</p><p><blockquote>标普500板块中,科技和非必需消费品领涨,均上涨约1.5%。</blockquote></p><p> Qualcomm shares jumped 12.7% as the company forecast better-than-expected profits and revenue for its current quarter on soaring demand for chips used in phones, cars and other internet-connected devices.</p><p><blockquote>高通股价上涨12.7%,该公司预测本季度利润和收入好于预期,原因是手机、汽车和其他互联网连接设备所用芯片的需求飙升。</blockquote></p><p> The Philadelphia SE Semiconductor index climbed 3.5%, with Nvidia soaring 12%.</p><p><blockquote>费城SE半导体指数上涨3.5%,英伟达飙升12%。</blockquote></p><p> Better-than-expected third-quarter earnings have helped lift sentiment for equities. With about 420 companies having reported, S&P 500 earnings are expected to have climbed 41.2% in the third quarter from a year earlier, according to Refinitiv IBES.</p><p><blockquote>好于预期的第三季度收益有助于提振股市情绪。根据Refinitiv IBES的数据,约有420家公司发布了财报,预计标普500第三季度盈利将同比增长41.2%。</blockquote></p><p> “The corporate earnings story remains quite bright,” said Craig Fehr, investment strategist at Edward Jones.</p><p><blockquote>爱德华·琼斯投资策略师克雷格·费尔表示:“企业盈利情况仍然相当光明。”</blockquote></p><p> “The market is rewarding companies that are beating and upping their outlook, and the market is punishing companies that are missing their estimates in the quarter and more importantly, perhaps, signaling a more sour outlook.”</p><p><blockquote>“市场正在奖励那些超出预期并上调前景的公司,而市场正在惩罚那些本季度未达到预期的公司,也许更重要的是,这预示着前景更加糟糕。”</blockquote></p><p> Moderna shares tumbled about 18% as the company slashed the 2021 sales forecast for its COVID-19 vaccine by as much as $5 billion, grappling to fill vials and distribute them to meet unprecedented world demand. Moderna shares weighed on the S&P 500 healthcare sector, which fell 0.8%.</p><p><blockquote>Moderna股价暴跌约18%,该公司将其COVID-19疫苗2021年的销售预测削减了多达50亿美元,并努力灌装和分销小瓶,以满足前所未有的全球需求。Moderna股价拖累标普500医疗保健板块,该板块下跌0.8%。</blockquote></p><p> Data showed the number of Americans filing new claims for unemployment benefits fell to the lowest level in nearly 20 months last week, suggesting the economy was regaining momentum. Investors will get a critical view of the economy with the monthly jobs report on Friday.</p><p><blockquote>数据显示,上周美国新申请失业救济人数降至近20个月来的最低水平,表明经济正在恢复动力。投资者将从周五的月度就业报告中获得对经济的批判性看法。</blockquote></p><p> Declining issues outnumbered advancing ones on the NYSE by a 1.12-to-1 ratio; on Nasdaq, a 1.24-to-1 ratio favored decliners.</p><p><blockquote>纽约证券交易所下跌股与上涨股的比例为1.12比1;在纳斯达克,1.24比1的比率有利于下跌股。</blockquote></p><p> The S&P 500 posted 75 new 52-week highs and five new lows; the Nasdaq Composite recorded 224 new highs and 38 new lows.</p><p><blockquote>标普500创下75个52周新高和5个新低;纳斯达克综合指数录得224个新高和38个新低。</blockquote></p><p> About 11.3 billion shares changed hands in U.S. exchanges, above the 10.4 billion daily average over the last 20 sessions.</p><p><blockquote>美国交易所约有113亿股易手,高于过去20个交易日104亿股的日均水平。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源:<a href=\"https://www.reuters.com/article/usa-stocks/us-stocks-sp-500-nasdaq-extend-record-streaks-with-boost-from-chip-growth-shares-idUSL1N2RV2T0\">Reuters</a></p>\n<p>为提升您的阅读体验,我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"161125":"标普500","513500":"标普500ETF博时","OEF":"标普100指数ETF-iShares",".SPX":"S&P 500 Index","SH":"做空标普500-Proshares","OEX":"标普100","SSO":"2倍做多标普500ETF-ProShares","UPRO":"三倍做多标普500ETF-ProShares",".DJI":"道琼斯","SDS":"两倍做空标普500 ETF-ProShares","IVV":"标普500ETF-iShares","SPXU":"三倍做空标普500ETF-ProShares",".IXIC":"NASDAQ Composite"},"source_url":"https://www.reuters.com/article/usa-stocks/us-stocks-sp-500-nasdaq-extend-record-streaks-with-boost-from-chip-growth-shares-idUSL1N2RV2T0","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1128227989","content_text":"(Reuters) - The S&P 500 and Nasdaq rose on Thursday, extending their streaks of record high closes to six sessions, as chipmaker stocks surged following Qualcomm’s strong financial forecast and investors digested the Federal Reserve’s decision to start reducing its monthly bond purchases.\nThe Dow Jones Industrial Average posted a slim loss, ending its streak of record closes at four. Declines in shares of banks JPMorgan Chase & Co and Goldman Sachs Group weighed on the blue-chip index.\nFinancials dropped 1.3%, most among S&P 500 sectors, as U.S. Treasury yields fell, with the market unwinding expectations of quicker Fed rate hikes a day after the central bank signaled it was in no hurry to do so.\n“The growth side of the market is seeing more positive results today as they are benefiting from the falling yields that are developing,” said Matthew Miskin, co-chief investment strategist at John Hancock Investment Management.\n“The market had been positioning for higher yields in general given the Fed announcement of tapering. As we walked in today, there has been a reversal in that.”\nThe Dow Jones Industrial Average fell 33.35 points, or 0.09%, to 36,124.23, the S&P 500 gained 19.49 points, or 0.42%, to 4,680.06 and the Nasdaq Composite added 128.72 points, or 0.81%, to 15,940.31.\nThe S&P 500 growth index rose 1.2% while the S&P 500 value index fell 0.5%.\nAmong S&P 500 sectors, tech and consumer discretionary led the way, both rising about 1.5%.\nQualcomm shares jumped 12.7% as the company forecast better-than-expected profits and revenue for its current quarter on soaring demand for chips used in phones, cars and other internet-connected devices.\nThe Philadelphia SE Semiconductor index climbed 3.5%, with Nvidia soaring 12%.\nBetter-than-expected third-quarter earnings have helped lift sentiment for equities. With about 420 companies having reported, S&P 500 earnings are expected to have climbed 41.2% in the third quarter from a year earlier, according to Refinitiv IBES.\n“The corporate earnings story remains quite bright,” said Craig Fehr, investment strategist at Edward Jones.\n“The market is rewarding companies that are beating and upping their outlook, and the market is punishing companies that are missing their estimates in the quarter and more importantly, perhaps, signaling a more sour outlook.”\nModerna shares tumbled about 18% as the company slashed the 2021 sales forecast for its COVID-19 vaccine by as much as $5 billion, grappling to fill vials and distribute them to meet unprecedented world demand. Moderna shares weighed on the S&P 500 healthcare sector, which fell 0.8%.\nData showed the number of Americans filing new claims for unemployment benefits fell to the lowest level in nearly 20 months last week, suggesting the economy was regaining momentum. Investors will get a critical view of the economy with the monthly jobs report on Friday.\nDeclining issues outnumbered advancing ones on the NYSE by a 1.12-to-1 ratio; on Nasdaq, a 1.24-to-1 ratio favored decliners.\nThe S&P 500 posted 75 new 52-week highs and five new lows; the Nasdaq Composite recorded 224 new highs and 38 new lows.\nAbout 11.3 billion shares changed hands in U.S. exchanges, above the 10.4 billion daily average over the last 20 sessions.","news_type":1,"symbols_score_info":{"161125":0.9,"513500":0.9,".SPX":0.9,"SPXU":0.9,"OEF":0.9,"SDS":0.9,"SH":0.9,"SSO":0.9,"UPRO":0.9,"IVV":0.9,"ESmain":0.9,".IXIC":0.9,"OEX":0.9,".DJI":0.9}},"isVote":1,"tweetType":1,"viewCount":624,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":846297684,"gmtCreate":1636084078872,"gmtModify":1636084102302,"author":{"id":"3581894830339885","authorId":"3581894830339885","name":"Desmondsim","avatar":"https://static.tigerbbs.com/9484cf4599b477a3985c44fe04da87b3","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581894830339885","idStr":"3581894830339885"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>Nicee","listText":"<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>Nicee","text":"$Apple(AAPL)$Nicee","images":[{"img":"https://static.tigerbbs.com/af93d0dc43b1f40f281e1f70e95cff66","width":"1125","height":"2196"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/846297684","isVote":1,"tweetType":1,"viewCount":901,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":846294508,"gmtCreate":1636084065543,"gmtModify":1636084067366,"author":{"id":"3581894830339885","authorId":"3581894830339885","name":"Desmondsim","avatar":"https://static.tigerbbs.com/9484cf4599b477a3985c44fe04da87b3","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581894830339885","idStr":"3581894830339885"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/PTON\">$Peloton Interactive, Inc.(PTON)$</a>Nicee","listText":"<a href=\"https://laohu8.com/S/PTON\">$Peloton Interactive, Inc.(PTON)$</a>Nicee","text":"$Peloton Interactive, Inc.(PTON)$Nicee","images":[{"img":"https://static.tigerbbs.com/25444e094460b47f345355f4a121a130","width":"1125","height":"3074"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/846294508","isVote":1,"tweetType":1,"viewCount":398,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":841274095,"gmtCreate":1635920227429,"gmtModify":1635920227558,"author":{"id":"3581894830339885","authorId":"3581894830339885","name":"Desmondsim","avatar":"https://static.tigerbbs.com/9484cf4599b477a3985c44fe04da87b3","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581894830339885","idStr":"3581894830339885"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/841274095","repostId":"2180736486","repostType":4,"isVote":1,"tweetType":1,"viewCount":462,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":843228052,"gmtCreate":1635834470218,"gmtModify":1635834470306,"author":{"id":"3581894830339885","authorId":"3581894830339885","name":"Desmondsim","avatar":"https://static.tigerbbs.com/9484cf4599b477a3985c44fe04da87b3","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581894830339885","idStr":"3581894830339885"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/843228052","repostId":"2180061702","repostType":4,"isVote":1,"tweetType":1,"viewCount":587,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":843221249,"gmtCreate":1635834442727,"gmtModify":1635834442813,"author":{"id":"3581894830339885","authorId":"3581894830339885","name":"Desmondsim","avatar":"https://static.tigerbbs.com/9484cf4599b477a3985c44fe04da87b3","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581894830339885","idStr":"3581894830339885"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ETSY\">$Etsy(ETSY)$</a>Nicee","listText":"<a href=\"https://laohu8.com/S/ETSY\">$Etsy(ETSY)$</a>Nicee","text":"$Etsy(ETSY)$Nicee","images":[{"img":"https://static.tigerbbs.com/bb7257f35ed57a21932cf696ee3da285","width":"1125","height":"3164"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/843221249","isVote":1,"tweetType":1,"viewCount":514,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0}],"hots":[{"id":824750664,"gmtCreate":1634357826274,"gmtModify":1634357826526,"author":{"id":"3581894830339885","authorId":"3581894830339885","name":"Desmondsim","avatar":"https://static.tigerbbs.com/9484cf4599b477a3985c44fe04da87b3","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581894830339885","idStr":"3581894830339885"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/824750664","repostId":"2175146556","repostType":4,"isVote":1,"tweetType":1,"viewCount":380,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":145460659,"gmtCreate":1626238032671,"gmtModify":1633928724184,"author":{"id":"3581894830339885","authorId":"3581894830339885","name":"Desmondsim","avatar":"https://static.tigerbbs.com/9484cf4599b477a3985c44fe04da87b3","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581894830339885","idStr":"3581894830339885"},"themes":[],"htmlText":"Wowew","listText":"Wowew","text":"Wowew","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/145460659","repostId":"2151560584","repostType":4,"isVote":1,"tweetType":1,"viewCount":408,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":873684439,"gmtCreate":1636938412602,"gmtModify":1636938412692,"author":{"id":"3581894830339885","authorId":"3581894830339885","name":"Desmondsim","avatar":"https://static.tigerbbs.com/9484cf4599b477a3985c44fe04da87b3","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581894830339885","idStr":"3581894830339885"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":10,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/873684439","repostId":"1102708415","repostType":4,"isVote":1,"tweetType":1,"viewCount":3704,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":120740804,"gmtCreate":1624339462208,"gmtModify":1634007530566,"author":{"id":"3581894830339885","authorId":"3581894830339885","name":"Desmondsim","avatar":"https://static.tigerbbs.com/9484cf4599b477a3985c44fe04da87b3","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581894830339885","idStr":"3581894830339885"},"themes":[],"htmlText":"Pls like and comment","listText":"Pls like and comment","text":"Pls like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/120740804","repostId":"2145757030","repostType":4,"isVote":1,"tweetType":1,"viewCount":410,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":852710319,"gmtCreate":1635301893269,"gmtModify":1635301893393,"author":{"id":"3581894830339885","authorId":"3581894830339885","name":"Desmondsim","avatar":"https://static.tigerbbs.com/9484cf4599b477a3985c44fe04da87b3","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581894830339885","idStr":"3581894830339885"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/852710319","repostId":"1198138567","repostType":4,"repost":{"id":"1198138567","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1635289060,"share":"https://www.laohu8.com/m/news/1198138567?lang=zh_CN&edition=full","pubTime":"2021-10-27 06:57","market":"us","language":"en","title":"Microsoft beats revenue expectations<blockquote>微软营收超出预期</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1198138567","media":"Tiger Newspress","summary":"Microsoft shares edged 2% to a new high in extended trading Tuesday after the software and hardware maker reported fiscal first-quarter earnings that exceeded analysts’ estimates.Earnings:$2.27 per share, adjusted, vs. $2.07 as expected by analysts, according to Refinitiv.Revenue:$45.32 billion, vs. $43.97 billion as expected by analysts, according to Refinitiv.Overall, revenue rose 22% to $45.32 billion in the first quarter ended Sept. 30, beating expectations of about $43.97 billion.Net income","content":"<p>Microsoft shares edged 2% to a new high in extended trading Tuesday after the software and hardware maker reported fiscal first-quarter earnings that exceeded analysts’ estimates.</p><p><blockquote>在软件和硬件制造商微软公布的第一财季盈利超出分析师预期后,该公司股价周二在盘后交易中小幅上涨2%,创下新高。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/39a5f34928113f01cf2fd1dd31b1b3fa\" tg-width=\"849\" tg-height=\"619\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p> Here’s how the company did:</p><p><blockquote>该公司的做法如下:</blockquote></p><p> <ul> <li><b>Earnings:</b>$2.27 per share, adjusted, vs. $2.07 as expected by analysts, according to Refinitiv.</li> <li><b>Revenue:</b>$45.32 billion, vs. $43.97 billion as expected by analysts, according to Refinitiv.</li> </ul> Overall, revenue rose 22% to $45.32 billion in the first quarter ended Sept. 30, beating expectations of about $43.97 billion.</p><p><blockquote><ul><li><b>收益:</b>根据Refinitiv的数据,调整后每股2.27美元,而分析师预期为2.07美元。</li><li><b>收入:</b>根据Refinitiv的数据,为453.2亿美元,而分析师预期为439.7亿美元。</li></ul>总体而言,截至9月30日的第一季度营收增长22%至453.2亿美元,超出预期约439.7亿美元。</blockquote></p><p> Net income rose to $20.51 billion, or $2.71 per share. The company said its results included a $3.3 billion net income tax benefit.</p><p><blockquote>净利润升至205.1亿美元,即每股2.71美元。该公司表示,其业绩包括33亿美元的净所得税优惠。</blockquote></p><p> On an adjusted basis it earned $2.27 per share, trumping analyst expectations of $2.07 per share.</p><p><blockquote>调整后每股收益2.27美元,超出分析师预期的每股2.07美元。</blockquote></p><p> Microsoft said revenue from its largest and fastest growing \"Intelligent Cloud\" segment surged 31% to $17 billion. Analysts had expected a figure of $16.58 billion, according to Refinitiv data.</p><p><blockquote>微软表示,其规模最大、增长最快的“智能云”部门的收入飙升31%,达到170亿美元。根据Refinitiv的数据,分析师此前预计这一数字为165.8亿美元。</blockquote></p><p> Revenue growth for Azure, the company's flagship cloud-computing business, came in at 48% in constant currency to beat analysts' estimates of 47.5%, according to consensus data from Visible Alpha.</p><p><blockquote>Visible Alpha的一致数据显示,该公司旗舰云计算业务Azure的收入按固定汇率计算增长了48%,超出了分析师预期的47.5%。</blockquote></p><p> Azure's growth rate is the best direct measure of competition with rivals such as AWS and Google Cloud as Microsoft does not break out revenue from the cloud-computing unit.</p><p><blockquote>Azure的增长率是衡量与AWS和谷歌云等竞争对手竞争的最佳直接指标,因为微软没有公布云计算部门的收入。</blockquote></p><p> Microsoft appeared to hold off Google Cloud's rising challenge. Google Cloud said on Tuesday its revenue surged by 45% to $4.99 billion, but failed to live up to estimates of $5.2 billion.</p><p><blockquote>微软似乎挡住了谷歌云日益严峻的挑战。谷歌云周二表示,其收入飙升45%至49.9亿美元,但未能达到52亿美元的预期。</blockquote></p><p> Revenue at the firm's other business units that house Windows software, Teams messaging service and LinkedIn professional social networking platform also beat analyst expectations.</p><p><blockquote>该公司其他业务部门(包括Windows软件、Teams消息服务和LinkedIn专业社交网络平台)的收入也超出了分析师的预期。</blockquote></p><p> The supply chain issues affecting much of the global tech industry had mixed consequences for Microsoft.</p><p><blockquote>影响全球大部分科技行业的供应链问题给微软带来了复杂的后果。</blockquote></p><p> Amy Hood, executive vice president and chief financial officer of Microsoft, said that while the company did see some higher costs for building out data centers, it was able to mitigate those costs, with gross margins for its commercial cloud segment rising after discounting the impact of recent changes in accounting for data center gear.</p><p><blockquote>微软执行副总裁兼首席财务官Amy Hood表示,虽然该公司确实看到建设数据中心的成本有所上升,但它能够降低这些成本,在扣除数据中心设备会计近期变化的影响后,其商业云部门的毛利率有所上升。</blockquote></p><p> Microsoft said sales of its Xbox gaming consoles and accessories were up 166% as it continues to see strong demand for new models after the pandemic forced millions to seek entertainment at home.</p><p><blockquote>微软表示,其Xbox游戏机和配件的销量增长了166%,因为在疫情迫使数百万人在家寻求娱乐后,该公司继续看到对新型号的强劲需求。</blockquote></p><p> But Microsoft and its rivals have been unable to keep up with demand because of the global chip crunch.</p><p><blockquote>但由于全球芯片紧缩,微软及其竞争对手无法满足需求。</blockquote></p><p> Hood told Reuters the company expects Xbox demand to continue to exceed supply.</p><p><blockquote>胡德告诉路透社,该公司预计Xbox需求将继续超过供应。</blockquote></p><p> Microsoft's revenue from selling Windows to PC makers grew 10% year over year, beating the overall PC market, which only grew 3.9% over the same period because of supply constraints, according to data from IDC.</p><p><blockquote>IDC的数据显示,微软向PC制造商销售Windows的收入同比增长10%,超过了整体PC市场,由于供应限制,同期PC市场仅增长了3.9%。</blockquote></p><p> Hood said that the company was able to outperform in the PC market because of its strength in selling licenses for Windows destined for corporate customers, where it gets more revenue per license and has better market share.</p><p><blockquote>胡德表示,该公司之所以能够在PC市场表现出色,是因为它在向企业客户销售Windows许可证方面具有实力,每个许可证可以获得更多收入,并拥有更好的市场份额。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Microsoft beats revenue expectations<blockquote>微软营收超出预期</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMicrosoft beats revenue expectations<blockquote>微软营收超出预期</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-10-27 06:57</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Microsoft shares edged 2% to a new high in extended trading Tuesday after the software and hardware maker reported fiscal first-quarter earnings that exceeded analysts’ estimates.</p><p><blockquote>在软件和硬件制造商微软公布的第一财季盈利超出分析师预期后,该公司股价周二在盘后交易中小幅上涨2%,创下新高。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/39a5f34928113f01cf2fd1dd31b1b3fa\" tg-width=\"849\" tg-height=\"619\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p> Here’s how the company did:</p><p><blockquote>该公司的做法如下:</blockquote></p><p> <ul> <li><b>Earnings:</b>$2.27 per share, adjusted, vs. $2.07 as expected by analysts, according to Refinitiv.</li> <li><b>Revenue:</b>$45.32 billion, vs. $43.97 billion as expected by analysts, according to Refinitiv.</li> </ul> Overall, revenue rose 22% to $45.32 billion in the first quarter ended Sept. 30, beating expectations of about $43.97 billion.</p><p><blockquote><ul><li><b>收益:</b>根据Refinitiv的数据,调整后每股2.27美元,而分析师预期为2.07美元。</li><li><b>收入:</b>根据Refinitiv的数据,为453.2亿美元,而分析师预期为439.7亿美元。</li></ul>总体而言,截至9月30日的第一季度营收增长22%至453.2亿美元,超出预期约439.7亿美元。</blockquote></p><p> Net income rose to $20.51 billion, or $2.71 per share. The company said its results included a $3.3 billion net income tax benefit.</p><p><blockquote>净利润升至205.1亿美元,即每股2.71美元。该公司表示,其业绩包括33亿美元的净所得税优惠。</blockquote></p><p> On an adjusted basis it earned $2.27 per share, trumping analyst expectations of $2.07 per share.</p><p><blockquote>调整后每股收益2.27美元,超出分析师预期的每股2.07美元。</blockquote></p><p> Microsoft said revenue from its largest and fastest growing \"Intelligent Cloud\" segment surged 31% to $17 billion. Analysts had expected a figure of $16.58 billion, according to Refinitiv data.</p><p><blockquote>微软表示,其规模最大、增长最快的“智能云”部门的收入飙升31%,达到170亿美元。根据Refinitiv的数据,分析师此前预计这一数字为165.8亿美元。</blockquote></p><p> Revenue growth for Azure, the company's flagship cloud-computing business, came in at 48% in constant currency to beat analysts' estimates of 47.5%, according to consensus data from Visible Alpha.</p><p><blockquote>Visible Alpha的一致数据显示,该公司旗舰云计算业务Azure的收入按固定汇率计算增长了48%,超出了分析师预期的47.5%。</blockquote></p><p> Azure's growth rate is the best direct measure of competition with rivals such as AWS and Google Cloud as Microsoft does not break out revenue from the cloud-computing unit.</p><p><blockquote>Azure的增长率是衡量与AWS和谷歌云等竞争对手竞争的最佳直接指标,因为微软没有公布云计算部门的收入。</blockquote></p><p> Microsoft appeared to hold off Google Cloud's rising challenge. Google Cloud said on Tuesday its revenue surged by 45% to $4.99 billion, but failed to live up to estimates of $5.2 billion.</p><p><blockquote>微软似乎挡住了谷歌云日益严峻的挑战。谷歌云周二表示,其收入飙升45%至49.9亿美元,但未能达到52亿美元的预期。</blockquote></p><p> Revenue at the firm's other business units that house Windows software, Teams messaging service and LinkedIn professional social networking platform also beat analyst expectations.</p><p><blockquote>该公司其他业务部门(包括Windows软件、Teams消息服务和LinkedIn专业社交网络平台)的收入也超出了分析师的预期。</blockquote></p><p> The supply chain issues affecting much of the global tech industry had mixed consequences for Microsoft.</p><p><blockquote>影响全球大部分科技行业的供应链问题给微软带来了复杂的后果。</blockquote></p><p> Amy Hood, executive vice president and chief financial officer of Microsoft, said that while the company did see some higher costs for building out data centers, it was able to mitigate those costs, with gross margins for its commercial cloud segment rising after discounting the impact of recent changes in accounting for data center gear.</p><p><blockquote>微软执行副总裁兼首席财务官Amy Hood表示,虽然该公司确实看到建设数据中心的成本有所上升,但它能够降低这些成本,在扣除数据中心设备会计近期变化的影响后,其商业云部门的毛利率有所上升。</blockquote></p><p> Microsoft said sales of its Xbox gaming consoles and accessories were up 166% as it continues to see strong demand for new models after the pandemic forced millions to seek entertainment at home.</p><p><blockquote>微软表示,其Xbox游戏机和配件的销量增长了166%,因为在疫情迫使数百万人在家寻求娱乐后,该公司继续看到对新型号的强劲需求。</blockquote></p><p> But Microsoft and its rivals have been unable to keep up with demand because of the global chip crunch.</p><p><blockquote>但由于全球芯片紧缩,微软及其竞争对手无法满足需求。</blockquote></p><p> Hood told Reuters the company expects Xbox demand to continue to exceed supply.</p><p><blockquote>胡德告诉路透社,该公司预计Xbox需求将继续超过供应。</blockquote></p><p> Microsoft's revenue from selling Windows to PC makers grew 10% year over year, beating the overall PC market, which only grew 3.9% over the same period because of supply constraints, according to data from IDC.</p><p><blockquote>IDC的数据显示,微软向PC制造商销售Windows的收入同比增长10%,超过了整体PC市场,由于供应限制,同期PC市场仅增长了3.9%。</blockquote></p><p> Hood said that the company was able to outperform in the PC market because of its strength in selling licenses for Windows destined for corporate customers, where it gets more revenue per license and has better market share.</p><p><blockquote>胡德表示,该公司之所以能够在PC市场表现出色,是因为它在向企业客户销售Windows许可证方面具有实力,每个许可证可以获得更多收入,并拥有更好的市场份额。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MSFT":"微软"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1198138567","content_text":"Microsoft shares edged 2% to a new high in extended trading Tuesday after the software and hardware maker reported fiscal first-quarter earnings that exceeded analysts’ estimates.\n\nHere’s how the company did:\n\nEarnings:$2.27 per share, adjusted, vs. $2.07 as expected by analysts, according to Refinitiv.\nRevenue:$45.32 billion, vs. $43.97 billion as expected by analysts, according to Refinitiv.\n\nOverall, revenue rose 22% to $45.32 billion in the first quarter ended Sept. 30, beating expectations of about $43.97 billion.\nNet income rose to $20.51 billion, or $2.71 per share. The company said its results included a $3.3 billion net income tax benefit.\nOn an adjusted basis it earned $2.27 per share, trumping analyst expectations of $2.07 per share.\nMicrosoft said revenue from its largest and fastest growing \"Intelligent Cloud\" segment surged 31% to $17 billion. Analysts had expected a figure of $16.58 billion, according to Refinitiv data.\nRevenue growth for Azure, the company's flagship cloud-computing business, came in at 48% in constant currency to beat analysts' estimates of 47.5%, according to consensus data from Visible Alpha.\nAzure's growth rate is the best direct measure of competition with rivals such as AWS and Google Cloud as Microsoft does not break out revenue from the cloud-computing unit.\nMicrosoft appeared to hold off Google Cloud's rising challenge. Google Cloud said on Tuesday its revenue surged by 45% to $4.99 billion, but failed to live up to estimates of $5.2 billion.\nRevenue at the firm's other business units that house Windows software, Teams messaging service and LinkedIn professional social networking platform also beat analyst expectations.\nThe supply chain issues affecting much of the global tech industry had mixed consequences for Microsoft.\nAmy Hood, executive vice president and chief financial officer of Microsoft, said that while the company did see some higher costs for building out data centers, it was able to mitigate those costs, with gross margins for its commercial cloud segment rising after discounting the impact of recent changes in accounting for data center gear.\nMicrosoft said sales of its Xbox gaming consoles and accessories were up 166% as it continues to see strong demand for new models after the pandemic forced millions to seek entertainment at home.\nBut Microsoft and its rivals have been unable to keep up with demand because of the global chip crunch.\nHood told Reuters the company expects Xbox demand to continue to exceed supply.\nMicrosoft's revenue from selling Windows to PC makers grew 10% year over year, beating the overall PC market, which only grew 3.9% over the same period because of supply constraints, according to data from IDC.\nHood said that the company was able to outperform in the PC market because of its strength in selling licenses for Windows destined for corporate customers, where it gets more revenue per license and has better market share.","news_type":1,"symbols_score_info":{"MSFT":0.9}},"isVote":1,"tweetType":1,"viewCount":247,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":856074512,"gmtCreate":1635135633974,"gmtModify":1635135634228,"author":{"id":"3581894830339885","authorId":"3581894830339885","name":"Desmondsim","avatar":"https://static.tigerbbs.com/9484cf4599b477a3985c44fe04da87b3","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581894830339885","idStr":"3581894830339885"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/856074512","repostId":"1167039476","repostType":4,"isVote":1,"tweetType":1,"viewCount":636,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":170436521,"gmtCreate":1626445128263,"gmtModify":1633926669309,"author":{"id":"3581894830339885","authorId":"3581894830339885","name":"Desmondsim","avatar":"https://static.tigerbbs.com/9484cf4599b477a3985c44fe04da87b3","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581894830339885","idStr":"3581894830339885"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/170436521","repostId":"1183334651","repostType":4,"repost":{"id":"1183334651","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1626444637,"share":"https://www.laohu8.com/m/news/1183334651?lang=zh_CN&edition=full","pubTime":"2021-07-16 22:10","market":"us","language":"en","title":"Exela Technologies soars 10% amid listing of option contracts on NYSE Arca<blockquote>Exela Technologies在纽约证券交易所Arca上市期权合约,股价飙升10%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1183334651","media":"Tiger Newspress","summary":"Exela Technologies rises 10% in early trading while the company announced that NYSE Arca launched op","content":"<p>Exela Technologies rises 10% in early trading while the company announced that NYSE Arca launched options trading in XELA.</p><p><blockquote>Exela Technologies早盘上涨10%,该公司宣布纽约证券交易所Arca推出XELA期权交易。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/94f4a006aac82b04b4e1ee25a23b79b6\" tg-width=\"1276\" tg-height=\"597\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> Trading is expected to begin July 16.</p><p><blockquote>交易预计将于7月16日开始。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Exela Technologies soars 10% amid listing of option contracts on NYSE Arca<blockquote>Exela Technologies在纽约证券交易所Arca上市期权合约,股价飙升10%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nExela Technologies soars 10% amid listing of option contracts on NYSE Arca<blockquote>Exela Technologies在纽约证券交易所Arca上市期权合约,股价飙升10%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-07-16 22:10</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Exela Technologies rises 10% in early trading while the company announced that NYSE Arca launched options trading in XELA.</p><p><blockquote>Exela Technologies早盘上涨10%,该公司宣布纽约证券交易所Arca推出XELA期权交易。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/94f4a006aac82b04b4e1ee25a23b79b6\" tg-width=\"1276\" tg-height=\"597\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> Trading is expected to begin July 16.</p><p><blockquote>交易预计将于7月16日开始。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"XELA":"Exela Technologies, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1183334651","content_text":"Exela Technologies rises 10% in early trading while the company announced that NYSE Arca launched options trading in XELA.\n\nTrading is expected to begin July 16.","news_type":1,"symbols_score_info":{"XELA":0.9}},"isVote":1,"tweetType":1,"viewCount":315,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":828599361,"gmtCreate":1633921247770,"gmtModify":1633921247850,"author":{"id":"3581894830339885","authorId":"3581894830339885","name":"Desmondsim","avatar":"https://static.tigerbbs.com/9484cf4599b477a3985c44fe04da87b3","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581894830339885","idStr":"3581894830339885"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/828599361","repostId":"2174971913","repostType":4,"isVote":1,"tweetType":1,"viewCount":508,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":823132986,"gmtCreate":1633596555463,"gmtModify":1633596555745,"author":{"id":"3581894830339885","authorId":"3581894830339885","name":"Desmondsim","avatar":"https://static.tigerbbs.com/9484cf4599b477a3985c44fe04da87b3","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581894830339885","idStr":"3581894830339885"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/823132986","repostId":"2173948949","repostType":4,"isVote":1,"tweetType":1,"viewCount":602,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":888562178,"gmtCreate":1631508923194,"gmtModify":1631891383385,"author":{"id":"3581894830339885","authorId":"3581894830339885","name":"Desmondsim","avatar":"https://static.tigerbbs.com/9484cf4599b477a3985c44fe04da87b3","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3581894830339885","idStr":"3581894830339885"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/888562178","repostId":"2166377033","repostType":4,"isVote":1,"tweetType":1,"viewCount":509,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}